Annual Report • Sep 30, 2011
Annual Report
Open in ViewerOpens in native device viewer
for the year ended 30 September 2011
The objective of The Income & Growth VCT plc ("I&G" or "the Company") is to provide investors with an attractive return, by maximising the stream of dividend distributions from the income and capital gains generated by a diverse and carefully selected portfolio of investments.
The Company invests in companies at various stages of development. In some instances this may include investments in new and secondary issues of companies which may already be quoted on the Alternative Investment Market ("AiM") or PLUS.
| Financial Highlights | 1 |
|---|---|
| Chairman's Statement | 5 |
| Investment Policy | 11 |
| Investment Manager's Review | 13 |
| Investment Portfolio Summary | 22 |
| Board of Directors | 25 |
| Directors' Report | 27 |
| Directors' Remuneration Report | 37 |
| Corporate Governance Statement | 40 |
| Statement of Directors' Responsibilities | 48 |
| Independent Auditor's Report | 49 |
| Primary Financial Statements | 51 |
| Notes to the Accounts | 55 |
| Notice of Annual General Meeting | 76 |
| Corporate Information | 79 |
The net assets of the 'O' and 'S' Share Funds were merged to form one share class of Ordinary Shares on 29 March 2010. At that date, the net assets of the merged VCT were £35.7 million, which have increased to £49.2 million at 30 September 2011.
Increase of 25.9% in net asset value (NAV) total return to Shareholders
Dividends totalling 4 pence per share were paid during the year and a special capital dividend of 20 pence per share has been declared since the year-end subsequent to the realisation of App-DNA. Further, a final dividend of 4 pence per share will be recommended to Shareholders at the AGM. These payments will bring cumulative dividends paid to date to 28.5 pence per share (43.7 pence per original Share invested for Shareholders who originally invested in the former 'O' Share Fund).
Increase of 9.8% in share price total return to Shareholders
Strong liquidity has been maintained in the context of continuing market volatility
The merger was effected by converting the relevant 'O' Shares into 'S' Shares using a conversion ratio of 0.7578. All the issued and unissued 'S' Shares were subsequently redesignated as Ordinary Shares on a 1 for 1 basis.
To help Shareholders in each former share class understand the recent trend in performance of their investment, comparative data for each former share class is shown below:-
| Net assets |
NAV per Share |
Cumulative dividends paid per Share |
NAV total return to Shareholders since launch per Share |
Share price |
Share price total return to Shareholders |
|
|---|---|---|---|---|---|---|
| (£m) | (p) | (p) | (p) | (p)2 | (p) | |
| Ordinary Shares ('S' Shares until 29 March 2010) | ||||||
| As at 30 September 20111 | 49.2 | 120.8 | 4.5 | 125.3 | 91.6 | 96.1 |
| As at 30 September 2010 | 36.6 | 99.0 | 0.5 | 99.5 | 87.0 | 87.5 |
| As at 30 September 2009 | 11.0 | 93.2 | 0.0 | 93.2 | 94.5 | 94.5 |
| As at 30 September 2008 | 11.2 | 94.6 | 0.0 | 94.6 | 100.0 | 100.0 |
| At close of Offer for subscription |
11.2 | 94.5 | 0.0 | 94.5 | 100.0 | 100.0 |
1 The data for all periods shows the return on an initial subscription price of 100p at the date of inception of each Fund. Data as at 30 September 2011 is supported by the table overleaf divided by £10,000.
2 Source: London Stock Exchange
Former 'S' Shares – S ordinary shares of 1p raised during the 2007/08 tax year and admitted to trading on 8 February 2008.
| Net assets |
NAV per Share |
Cumulative dividends paid per share |
NAV total return to Shareholders since launch |
Share price |
Share price total return to Shareholders |
|
|---|---|---|---|---|---|---|
| (£m) | (p) | (p) | per Share (p) |
(p)2 | (p) | |
| Former 'O' Shares (until 29 March 2010) | ||||||
| As at 30 September 20111 | – | 91.5 | 25.5 | 117.0 | – | – |
| As at 30 September 2010 | – | 75.0 | 22.5 | 97.5 | – | – |
| As at 30 September 2009 | 24.9 | 71.5 | 20.5 | 92.0 | 54.8 | 75.3 |
| As at 30 September 2008 | 29.6 | 83.6 | 16.5 | 100.1 | 79.5 | 96.0 |
1 The data for all periods shows the return on an initial subscription price of 100p at the date of inception of each Fund. Data as at 30 September 2011 is supported by the table below divided by £10,000.
2 Source: London Stock Exchange
The tables below show the NAV total returns at 30 September 2011 for a shareholder in each original class that invested £10,000 at £1 a share at each Fund's inception.
| Ordinary Shares 2007/081 |
Former 'O' Shares 2000/2001 |
||
|---|---|---|---|
| Original investment (10,000 shares at £1 each) | (£) | 10,000 | 10,000 |
| Number of shares held post merger | 10,000 | 7,578 | |
| Rate of income tax relief | % | 30% | 20%2 |
| Cost net of income tax relief | (£) | 7,000 | 8,000 |
| NAV at 30 September 2011 | (£) | 12,079 | 9,154 |
| Dividends paid to Shareholders since subscription | (£) | 450 | 2,548 |
| Total return (NAV basis) to Shareholders since subscription | (£) | 12,529 | 11,702 |
| Profit before income tax relief3 | (£) | 2,529 | 1,702 |
| Profit after income tax relief4 | (£) | 5,529 | 3,702 |
1 Formerly 'S' Shares
2 Additional capital gains tax deferral relief of up to £4,000 available to qualifying shareholders
3 NAV total return minus initial investment cost (before applicable income tax relief)
4 NAV total return minus cost net of income tax relief
The Board's current intention is to continue with its existing buy-back policy with the objective of maintaining the discount to NAV at which the shares trade at 10% or less. The discount for the Company's Ordinary Shares at 30 September 2011 was 10.9% (2010: 9.6%) based on the NAV at 30 June 2011 of 102.8 pence. The Share price has however risen considerably since the year-end to 109 pence, subsequent to the announcement of the realisation of App-DNA, in anticipation of the increase in the net asset value shown in these accounts.
Dividends paid include distributions from both income and capital
| Payment date | Ordinary Shares | Former 'O' Shares | |
|---|---|---|---|
| (former 'S' Shares) | (dividends paid on original holding) | ||
| In respect of year ended | (p) per share | (p) per share | |
| 30 September 2001 | 18 February 2002 | – | 1.20 pence |
| 30 September 2002 | 12 February 2003 | – | 1.75 pence |
| 30 September 2003 | 11 February 2004 | – | 1.25 pence |
| 30 September 2004 | 04 February 2005 | – | 1.25 pence |
| 30 September 2005 | 14 February 2006 | – | 0.75 pence |
| 30 September 2006 (interim) | 14 February 2006 | – | 2.50 pence |
| 30 September 2006 | 15 February 2007 | – | 0.75 pence |
| 30 September 2007 (interim) | 15 February 2007 | – | 3.00 pence |
| 30 September 2007 (interim) | 24 October 2007 | – | 2.00 pence |
| 30 September 2007 | 15 February 2008 | – | 2.00 pence |
| 30 September 2008 | 16 February 2009 | – | 4.00 pence |
| 30 September 2009 | 17 March 2010 | 0.50 pence | 2.00 pence |
| 30 September 2010 | 22 February 2011 | 2.00 pence | 1.52 pence1 |
| 30 September 2010 | 28 March 2011 | 2.00 pence | 1.52 pence1 |
| Cumulative dividends paid | 4.50 pence | 25.49 pence |
1 The dividends paid after the Merger on the Ordinary Shares have also been shown in the data for the former 'O' Shares. Such dividends have been converted at the merger ratio, so that a former 'O' Fund Shareholder can see the total dividends received on their original holding.
In addition to the special capital dividend of 20 pence per share declared since the year-end, a final dividend of 4 pence per share comprising 2 pence from income and 2 pence from capital will be recommended to Shareholders at the Annual General Meeting of the Company to be held on 9 February 2012. The dividend will be paid on 15 February 2012 to Shareholders on the Register on 20 January 2012.
In the graph below, the total return figures have been rebased to 100 at 8 February 2008, the date on which the Company's Ordinary Shares were first admitted to trading.
Source: Matrix Corporate Capital LLP
Note: The share price and net asset value (NAV) total return comprise the share price and NAV respectively per share assuming the dividends paid were re-invested on the date on which the shares were quoted ex-dividend in respect of each dividend.
I am pleased to present to Shareholders the eleventh Annual Report of the Company for the year ended 30 September 2011.
The persisting uncertainty in the UK and global economies has continued to impact on the Company during the year under review. The signs in the first half of the year of a possible return to comparative stability failed to materialise and we are now experiencing a resurgence of the earlier volatility, particularly as a result of debt problems in several of the Eurozone countries.
However, since the year-end, in early November I am delighted that the Company was able to announce that it had sold its investment in App-DNA to Citrix Systems Inc. App-DNA is a leading specialist in Application Migration and Compatibility Software including App-DNA™ and AppTitude™ which it distributes to blue chip companies around the world. Citrix Systems has acquired all of the equity in App-DNA for a headline consideration of some US\$92 million. This delivered to the Company an initial consideration of £14.6 million and has resulted, therefore, in a material uplift in the NAV per share of the Company, a substantial portion of which was included in the fair value of this investment at 30 September 2011. In addition, approximately £1.8 million of further deferred consideration could be receivable over the next four years. The total consideration equates to a return of approximately 32 times the original investment. This outcome, of course, completely overshadows the performance of the remainder of the portfolio and has resulted in a special interim dividend being paid to all Shareholders – please see more information below. Shareholders should note that the Board anticipates that a performance incentive fee of up to an estimated £2.8 million could be payable for the current financial year ending 30 September 2012 in respect of this realisation.
As at 30 September 2011 the Company's NAV per Ordinary Share was 120.8 pence (30 September 2010: 99.0 pence). Adjusted for dividends paid to Shareholders during the year, this represents an increase of 26.0% over the twelve month period. This compares with an increase of 6.6% in the FTSE SmallCap Index and a rise of 10.5% in the FTSE AiM All-Share Index, both on a capital return basis.
Cumulative dividends paid, declared and proposed to date amount to 43.7 pence per original share invested for shareholders who originally invested in the former 'O' Share Fund (the 28 pence per share paid following the Merger has therefore been adjusted using the merger ratio of 0.7578) and 28.5 pence per Ordinary Share for shareholders who originally invested in the former 'S' Share Fund.
This has been a particularly active year for the portfolio as a whole. Overall, over the year the portfolio showed a net increase of £10.9 million in unrealised and £0.3 million in realised gains and it was valued at 125.5% of cost at the year-end. The valuation of the portfolio at the year-end was £37.1 million with the MPEP portfolio being valued at £23.9 million and the ex-Foresight portfolio at £13.2 million.
During the year a total of some £2.7 million was placed into new investments (excluding the £3 million already invested in each of the acquisition vehicles, Aust, Apricot and Fullfield). In October 2010 I&G made a further investment into the acquisition vehicle, Aust, of £441,667 to support the MBO of RDL Recruitment Corporation, a European recruitment provider within the pharmaceutical, business intelligence and IT sector. The VCT's investment in this company now stands at £1.4 million. In December 2010, a new investment of £487,744 was made into Faversham House, a broadly based publishing business. In the same month £279,996 was invested into Omega Diagnostics, an AiM listed company specialising in in-vitro diagnostics for food intolerance, autoimmune diseases and infectious diseases.
A further investment into the acquisition vehicle Apricot of £193,906 was made to support the MBO of Automated Systems Group plc, a provider of printer and copier services. This brought the VCT's investment in this company to £1.2 million. The company has since changed its name to ASL Technology Holdings Limited. A further investment was then made in March 2011 of £575,884 to support the acquisition of Transcribe Copier Systems Limited. In July 2011 a further investment of £718,189 was put into the acquisition vehicle Fullfield Limited to support the MBO of Motorclean Group Limited, a provider of vehicle cleaning and valet services to the car dealership market. This brought I&G's investment in this company to £1.7 million.
It is a measure of the success of the Manager's efforts that the portfolio has required only £42,560 of additional funding despite the challenges that investee companies have faced. An additional loan stock investment of £42,446 was made into Monsal in July and August 2011 as part of a facility of £1.75 million to support the turnaround of Monsal.
Following the year-end, a new investment of £1,383,314 was provided as mezzanine finance as part of a £7.8m transaction to support the acquisition of the international intellectual property and assets of Lowe Alpine Srl (from administration in Italy) by Equip Outdoor Technologies Limited, a company specialising in owning and distributing clothing brands focused on the outdoor sector. A further new investment of £1,878,124 (including £1 million from Vanir) has been made to support the MBO of EMaC Limited, the UK's leading provider of outsourced service plans to franchised dealers in the automotive sector.
Finally, a further investment in the form of a loan of up to £1.5 million was committed in December 2011 into Image Source to help support the resolution of a legal dispute with a former employee and shareholder in that company.
I am pleased to be able to advise you that there were numerous loan stock repayments, totalling some £2.5 million, during the year. A full breakdown of the payments received can be found in the Manager's Review on page 15 of this Annual Report.
During the year there were four disposals which realised a total of £3.0 million. In January 2011, Campden Media was fully realised for a cash consideration of £287,239, compared to the year-end valuation at 30 September 2010 of £125,921. Together with interest paid over the life of the investment the total cash return was marginally above cost. In February 2011, HWA was disposed of, resulting in a total cash return over the life of this investment of £5,070,682, compared to the £1,422,320 originally invested. In July 2011, Amaldis was sold to LDC for net proceeds of £2,304,000, including accrued interest of £426,713 and £537,948 of loan stock issued by the acquirer. This realisation contributed to total proceeds of £4,170,000 to the Company over the life of the investment, representing a 4.2 times return on the Company's original investment of £1 million. Finally, the Company sold a total of 270,000 shares in Tikit plc at prices ranging from £1.97 to £2.75, realising a net total of £625,485 and representing a 2 times return on the original investment of £310,500. The VCT continues to retain a residual holding in this company.
Following the year-end, as I have detailed above, the Company sold its interest in AppDNA to Citrix Systems resulting in a substantial return on investment and in a material uplift to I&G's NAV which is largely reflected in the balance sheet as at 30 September 2011.
Also following the year-end in December 2011, the VCT made a partial disposal of its investment in DiGiCo to ISIS Equity Partners. The VCT received cash proceeds of £1,405,642 which, including previous repayments of £581,373, generates a return of 3 times cash return on this investment to date. In addition, the VCT continues to hold a residual loan stock and equity (1.57%) investment with an assumed valuation of £874,497.
Finally, the portfolio has seen two of its investments demerge during the year. In November 2010 Camwood completed the demerger of its App-DNA business. Following the demerger, I&G had an investment in each of Camwood Enterprises Limited and App-DNA Group Limited, the latter since sold as above. This comprised a 31.5% equity stake and a secured loan of £333,334 in both companies. Both companies are leading specialists in Application Migration SoftwareTM. Then in March 2011, VSI also completed the demerger of its two operating subsidiary companies creating two separate companies, namely MachineWorks Software Limited and LightWorks Software Limited. Following the repayment of the VSI secured loan (which was transferred to MachineWorks Software on the demerger) in April 2011, I&G now has a 9.2% equity stake in both companies.
A number of the investee companies have continued to trade strongly, in particular, DiGiCo, Iglu.com Holidays, ATG Media and Original Additions.
During the economic turmoil, both the Board and the Manager have continued to work to ensure that our cash deposits continue to remain as secure as possible. We have for some time been spreading our significant cash deposits with a number of the leading global cash funds rather than depositing all liquidity directly with individual banks, thereby reducing our exposure to any one particular bank. However, the current low level of interest rates on cash deposits means that it will continue to be difficult for the Company to pay dividends out of interest income from cash held. The Board and Manager both strongly believe that at this time the security and protection of the Company's capital is more important than striving for a small increase in deposit rates at the cost of much higher risk.
Cash and liquidity fund balances as at 30 September 2011 amounted to £13.3 million.
The revenue account has achieved a strong return this year, achieving a positive return of £864,072, compared to last year's loss of £50,860, an improvement of £914,932.
The strong increase in income over the year of £924,216 has been a significant factor in this turnaround. The main cause of this increase was a rise in loan stock interest of £770,663, £426,714 of which was due to interest recognised upon the disposal of Amaldis. The balance of the increase of £343,949 reflects the impact of a number of new investments made in the year, such as RDL Corporation, Faversham House, ASL Technology and Fullfield (Motorclean). In addition, Blaze Signs and Youngman recommenced loan interest payments, with Youngman also reducing its interest arrears.
Dividend income also rose by £164,726, due to increased dividends from Brookerpaks, DiGiCo, ATG Media and VSI, as well as a maiden dividend from CB Imports.
Other expenses have fallen in the year to £375,837 (2010: £513,840). Last year's revenue account was depressed by £75,516 of costs relating to the merger, while the higher levels of loan stock income this year have increased the tax charge borne by the revenue account by £176,808. Due to the Company's ability to offset some capital costs against revenue profits, the Company has no charge to tax.
Arising from the realisation of AppDNA, your Board declared a special interim capital dividend of 20 pence per share, for the year ending 30 September 2012, and this will be paid on 27 January 2012 to Shareholders on the Register on 30 December 2011.
A final dividend of 4 pence per new Ordinary Share, comprising 2 pence from income and 2 pence from capital, will be recommended to Shareholders at the Annual General Meeting of the Company to be held on 9 February 2012 for payment to shareholders on the register on 20 January 2012 on 15 February 2012.
The Company's Dividend Investment Scheme ("the Scheme") will apply to both of these dividends. The Scheme is a convenient, easy and cost effective way to build up your shareholding in the Company. Instead of receiving cash dividends you can elect to receive new shares in the Company. By opting to receive your dividend in this manner, there are three benefits to you:
Shareholders are allotted new ordinary shares which will, subject to your particular circumstances, attract VCT tax reliefs applicable for the tax year in which the shares are allotted. The tax relief currently available to investors in new VCT shares is 30% for the 2011/12 tax year for investments up to £200,000 in any one tax year; and
The Scheme also has one unique advantage. Under its terms, a member is able to re-invest at an advantageous price, being the average market price of the shares for the five business days prior to the dividend being paid. This price is likely to be at a discount of 10% to the underlying net asset value.
Elections under the Scheme should be received by the Scheme Administrator, Capita Registrars, by no later than 12 January 2012 in the case of the special dividend and 31 January 2012 in the case of the final dividend to ensure that you receive these dividends as shares.
Last year, 288 Shareholders, who between them held a total of 2,276,359 Ordinary Shares representing 5.9% of the Company were issued 52,473 Ordinary Shares on 22 February 2011 in respect of the Interim Dividend of 2 pence per share paid to Shareholders on 22 February 2011 at an issue price of 86.70 pence per share.
In addition, 419 Shareholders, who between them held a total of 3,590,904 Ordinary Shares representing 9.36% of the Company were issued 78,840 Ordinary Shares on 29 March 2011 in respect of the Final Dividend of 2.0 pence per share paid to Shareholders on 28 March 2011 at an issue price of 91.0 pence per share.
The issue price used for both dividends was equal to the average of the middle market price for the Shares taken from the London Stock Exchange Daily Official List for the five business days immediately preceding the payment date.
During the year ended 30 September 2011, the Company bought back 1,649,765 Ordinary Shares (year to 30 September 2010: 1,407,758, of which 1,037,821 were bought–back following the Merger) representing 4.46% of the Shares in issue at the beginning of the year at a total cost of £1,475,019 (year to 30 September 2010: £966,118) net of expenses. These shares were subsequently cancelled by the Company.
The Board regularly reviews its buyback policy and, given the less volatile outlook for the valuation of the portfolio, has significantly reduced the discount to NAV at which the Company's shares trade over the last year. At 22 December 2011, the mid-market price for the Company's shares was 109 pence, representing a premium of 6% to the last published NAV which was at 30 June 2011 but a discount of 9.7% to the NAV shown by these results. The share price has appreciated since the year-end, after the initial announcement of the sale of App-DNA.
A Joint Offer was launched on 12 November 2010 to raise £21 million in aggregate for the Company together with Matrix Income & Growth VCT plc and Matrix Income & Growth 4 VCT plc. The Offer closed on 30 June 2011 having raised £16.2 million across the three VCTs. This resulted in £5.4 million being raised for I&G.
The Company is intending to participate in a similar linked fundraising with these VCTs in 2012. The funds raised will bolster the Company's strong cash position to capitalise on new investment opportunities and spread our fixed running costs over a larger asset base.
Uncertainty, interspersed with rushes of optimism, has characterised global financial markets in recent months. With EU leaders having met recently to finally come up with a realistic solution to the Eurozone crisis, the markets ratcheted up the pressure. If these financial measures prove to be successful, markets could yet be heralding the end of the 'double-bottom'.
Unfortunately, inflation in the UK is much higher than forecast and proving to be very stubborn despite the Bank of England's assertions that it will fall back sharply in the coming months. The inflation figures will have caused little surprise to householders who have had to cope with rising fuel and food bills and also having seen the value of their savings and pensions shrink. So the immediate outlook for investors may not be one of recession but of quite high inflation against a back drop of historically low interest rates.
Although this Fund seeks to invest in profitable companies, and is no longer investing in technology high risk start ups, companies which are in most cases at a relatively early stage in their growth will be challenged by the economic environment over the coming winter. On the other hand, it is highly encouraging to be able to report that the majority of companies within the portfolio continue to trade profitably.
The Company continues to retain a significant cash position, having correctly limited investment during the downturn. Moreover, the forthcoming Fundraising Offer, which I have referred to above, will strengthen this position further. The unquoted sector has seen a return to more active levels, and the Board and Manager expect that a number of attractive investment opportunities will continue to be identified in the near term.
In summary, your Board is encouraged greatly by the portfolio which shows resilience and promise in spite of these difficult economic conditions and, of course, is delighted to be able to distribute much of the proceeds from the disposal of AppDNA.
May I remind you that the Company has its own website which is available at www.incomeandgrowthvct.co.uk.
Once again, I would like to take this opportunity to thank Shareholders for their continued support.
Colin Hook Chairman 22 December 2011
The Company's policy is to invest primarily in a diverse portfolio of UK unquoted companies. Investments are structured as part loan and part equity in order to receive regular income and to generate capital gains from trade sales and flotations of investee companies.
Investments are made selectively across a number of sectors, primarily in management buyout transactions (MBOs) i.e. to support incumbent management teams in acquiring the business they manage but do not yet own. Investments are primarily made in companies that are established and profitable.
The Company has a small legacy portfolio of investments in companies from its period prior to 30 September 2008, when it was a multi-manager VCT. This includes investments in early stage and technology companies and in companies quoted on the AiM or PLUS.
Uninvested funds are held in cash and lower risk money market funds.
The companies in which investments are made must have no more than £15 million, in the case of funds raised under the original prospectus in 2000/01, and £7 million, in the case of funds raised after 6 April 2006, (including the former 'S' Share Fund raised in 2007/08) of gross assets at the time of investment to be classed as a VCT qualifying holding.
The investment policy is designed to ensure that the Company continues to qualify and is approved as a VCT by HM Revenue & Customs ("HMRC"). Amongst other conditions, the Company may not invest more than 15% of its investments in a single company and must have at least 70% by value of its investments throughout the period in shares or securities comprised in VCT qualifying holdings, of which a minimum overall of 30% by value must be ordinary shares which carry no preferential rights (save as may be permitted under VCT rules). In addition, although the Company can invest less than 30% of an investment in a specific company in ordinary shares it must have at least 10% by value of its total investments in each VCT qualifying company in ordinary shares which carry no preferential rights (save as may be permitted under VCT rules).
The VCT regulations in respect of funds raised after 6 April 2011 changed, such that 70% of such funds must be invested in equity.
The Company initially holds its funds in a portfolio of readily realisable interest-bearing investments and deposits. The investment portfolio of qualifying investments is built up over a three year period with the aim of investing and maintaining at least 70% of net funds raised in qualifying investments.
Risk is spread by investing in a number of different businesses across different industry sectors. To reduce the risk of high exposure to equities, each qualifying investment is structured using a significant proportion of loan stock. Initial investments in VCT qualifying companies are generally made in amounts ranging from £200,000 to £1 million at cost. No holding in any one company will represent more than 10% of the value of the Company's investments at the time of investment. Ongoing monitoring of each investment is carried out by the Investment Manager, generally through taking a seat on the board of each VCT qualifying company.
The Company aims to invest in larger, more mature unquoted companies through investing alongside the three other VCTs advised by the Investment Manager with a similar investment policy. This enables the Company to participate in combined investments advised on by the Investment Manager of up to £5 million.
We continue to be encouraged by the positive signs of improvement that we have seen in our investment market both in terms of making investments and in realisations. There has been a clear upward trend in dealflow during the latter half of the year under review and we have seen a higher number of better priced, profitable, well-positioned and cash generative businesses seeking investment. We believe that this is due to two important converging factors which have combined to make our level of investment over recent months the highest for several years, without compromising the criteria that we use to assess the quality of potential investments. Firstly, the lower level of activity in the economy has led to greater realism amongst vendors regarding the value of their companies, leading to more realistic pricing. Secondly, our ability to invest significant levels of capital in a market lacking bank funding means that management buy-out ("MBO") teams are increasingly turning to us as a source of finance. In addition to the recent investments referred to below, there are a number of investment opportunities nearing completion that we are currently taking forward.
Furthermore, we are finding that there is significant trade interest and enthusiasm from private equity investors in the type of businesses in which we have invested. App-DNA was sold to Citrix Systems Inc. shortly after the year-end in November 2011 for an initial consideration of £14.6 million (plus a further approximately £1.8 million of deferred consideration which could be receivable over the next four years). The total consideration equates to a return of approximately 32 times the original investment making it the most successful realisation in the history of the Company.
We believe that the VCT's strategy of investing in MBO structured deals; supporting highly motivated management teams; focusing on acquiring established, profitable, positive cashflow businesses; and investing partly in income yielding loan stocks substantially increases the degree of downside protection to Shareholders' capital.
The volatility in the quoted markets which has continued after the year-end will inevitably have an effect on the valuations of those companies in our portfolio. The level of the FTSE All-Share index stood at 2,654 at 30 September 2011 when the investments were valued and since that date it has risen to 2,768. It is worth bearing in mind that many of the portfolio companies are valued partly by reference to the performance of companies trading in similar sectors within the FTSE All-Share index. However, as part of each investment is in loan stocks, the negative effect of any downward movement is mitigated to some degree.
Five new investments have been completed during the year under review totalling £5.7 million, three of which used the VCT's existing investments totalling £3 million in the acquisition vehicles Aust, Apricot Trading and Fullfield.
In the first of these in October last year, the Company used its existing investment of £1 million in the acquisition vehicle Aust to support the MBO of RDL Recruitment Corporation, a European recruitment provider within the pharmaceutical, business intelligence and IT sectors based in London and Woking. The VCT's total investment in this company following the MBO stands at £1.4 million.
Three new investments were made during December 2010. The first of these was to support the MBO of Faversham House Group Limited in which the VCT invested £487,744. Based in Croydon, this is an established media company providing magazines, exhibitions and online resources in the environment and sustainability, visual communications and building services sectors.
Again in December, the VCT invested £279,996 into the AiM-listed company Omega Diagnostics Group Plc. Based in Alva, Scotland this company provides high quality in vitro diagnostics products for use in hospitals, blood banks, clinics and laboratories in over 100 countries and specialises in the areas of food intolerance, autoimmune disease and infectious disease. The share price of Omega on AiM has risen since investment showing a 4% increase in value.
Finally in December, the VCT used its existing acquisition vehicle, Apricot Trading, to support the MBO of Automated Systems Group plc, a Cambridge-based printer and copier services business with a broad customer base of schools and SMEs. The VCT's total investment in this company, which changed its name to ASL Technology Holdings Limited, stood at £1.2 million following the MBO. The VCT made a follow-on investment of £575,884 in March 2011 to help fund the acquisition of Transcribe Copier Systems Limited bringing the VCT's current investment in this company to £1,769,790.
The final investment completed during the year under review was made in July 2011 when the VCT invested a further £718,189 into the acquisition vehicle Fullfield to enable it to support the MBO of Motorclean Group Limited, a provider of vehicle cleaning and valet services to the car dealership market, bringing the VCT's investment in this company to £1.7 million.
Two further new investments have been completed since the year-end in October and November to support the MBOs of Equip and EMaC.
In the first of these the VCT made an investment of £1,383,314 to provide mezzanine finance as part of a £7.8m transaction to support the acquisition of the international intellectual property and assets of Lowe Alpine Srl from administration in Italy by Equip Outdoor Technologies Limited, a company specialising in owning and distributing brands focused on the outdoor sector.
The second was a new investment of £1,878,124 to support the MBO of EMaC Limited, the UK's leading provider of outsourced Service Plans to franchised dealers in the automotive sector.
Our Operating Partner programme continues to pursue an active search for investment opportunities. The four remaining acquisition vehicles in which the Company invested in September 2010, Backbarrow, Bladon Castle Management, Rusland Management and Torvar are all seeking suitable investment opportunities in a variety of sectors including healthcare and wellbeing, food manufacturing and distribution, consumer products and retailing, brand management, database management, data mapping and management services. So far they have not found sufficiently attractive investment opportunities at the right price. Since the year-end, Bladon Castle Management has repaid its loan stock, and has been sold to a new acquisition vehicle, Watchgate Limited which has the intention of continuing to see similar opportunities, building on Bladon's work to date. Each of the acquisition vehicles is headed by an experienced Chairman, well-known to us, who is working closely with us in seeking to identify and complete investments in specific sectors relevant to their industry knowledge and experience. We have established these companies to provide time for us to identify and invest in suitable target companies at sufficiently attractive prices.
We have worked with our investee companies during the downturn in the economy to support and encourage them to make the necessary changes to ensure that they were in the best possible position to withstand the rigours of their situation. It is indicative of the success of these measures that Monsal is the only investment in the portfolio that has required further funding during the year under review. Earlier in the year, Monsal was experiencing completion delays on an existing contract and in the commissioning of new contracts. These delays led to a requirement for additional funding and following careful consideration, your Company approved a further loan stock investment of up to £106,000 as part of a £1.75 million fundraising alongside other Matrix VCTs and other shareholders. Three tranches of this new funding round totalling £42,446 have been drawn-down to date in separate tranches in July and August 2011 and these investments are held at cost. The terms of this new investment provided that it would rank ahead of the existing rounds of investment. With this additional funding, Monsal now has the ability to pursue a number of major contracts in the waste and water sector which will make the potential for recovery of value in the original investment a more realistic prospect. Since approval of this facility Monsal has materially advanced its negotiations on a number of new contracts.
Finally a further investment in the form of a loan of up to £1.5 million was committed in December 2011 into Image Source to help support the resolution of a legal dispute with a former employee and shareholder in that company. This company has continued to suffer from deteriorating trading conditions in a challenging market. It is now hoped that the company can improve its trading prospects.
We are pleased to report that a number of companies in the portfolio continue to be strongly cash generative and have repaid a total of £2.5 million (including any premiums paid) of their loan stock during the year to 30 September 2011. The payments received were from ATG Media which made a partial repayment of £111,111 in October 2010; DCG Group which repaid its outstanding loan in full remitting £204,772 to the Company in November 2010; Westway which made a further repayment of £99,681; Iglu.com Holidays which repaid its loan stock in full in February 2011, realising £997,675 for the Company; Vectair which repaid its loan in full in March 2011 remitting £195,017 to the Company; App-DNA Group which repaid its secured loan of £333,334 in full in March and July; Camwood Enterprises which repaid its loan of £333,334 in full in March and April; and MachineWorks which made a payment of £255,818 in full settlement of its loan in April 2011.
In January 2011 the Company realised its entire investment in Campden Media for a cash consideration of £287,239, compared to the 2010 year-end valuation of £125,921. This represented 85.8% of the total investment cost of £334,880. Together with interest paid over the life of the investment the total cash return was £349,013, representing 104.2% of cost.
In February 2011, the Company realised its residual investment in HWA for a small cash consideration. The total cash return over the life of this investment was £5,070,682, compared to amounts originally invested of £1,422,320, being 3.6 times cost.
Amaldis, the holding company for the Original Additions Group, a market leading manufacturer and distributor of beauty brands for the retail and professional markets in the UK and worldwide, was sold to LDC, the mid-market private equity house that is a part of Lloyds Banking Group, in July 2011 for net proceeds of £2,304,042, including interest of £426,714 and £537,948 of loan stock in Original Additions Topco Limited issued by the acquirer. This realisation contributed to total proceeds of £4,170,000 to the Company over the life of the investment, representing a 4.2 times return on the Company's original investment of £1 million.
The Company sold a total of 270,000 shares in Tikit Group plc during the year to 30 September 2011 realising total net proceeds of £625,485 which represented a 2.0 times realised return on the VCT's original investment cost of £310,500. The VCT continues to retain a residual holding in this company, which had a value of £458,094 at the year-end.
Following the year-end in November 2011, the VCT realised in full its investment in AppDNA by way of a trade sale to Citrix Systems Inc. The total cash consideration from the sale of £14,542,468 contributed to total proceeds to the Company over the life of the investment of £15,054,113, which represented a 29 times return on the Company's original investment of £514,090. This figure increases to 32 times if approximately £1.8 million of anticipated deferred consideration is brought into the calculation.
Also following the year-end in December 2011, the VCT made a partial disposal of its investment in DiGiCo to ISIS Equity Partners. The VCT received cash proceeds of £1,405,642 representing a 3 times cash return on this investment to date. In addition, the VCT continues to hold a residual loan stock and equity (1.57%) investment with an assumed valuation of £874,497.
The MPEP invested portfolio at 30 September 2011 comprised 33 investments with a cost of £21.2 million and valued at £23.9 million representing an uplift of 12.7% on cost.
The portfolio's performance as a whole continues to be robust. Some investee companies, of which DiGiCo, Iglu.com Holidays, ATG Media and Original Additions have been the most notable, have increased sales and profits despite the challenges of the economic environment.
The new investments made since last year, RDL Corporation, Faversham House, Omega Diagnostics Group plc, ASL Technology and Fullfield (Motorclean Group) are all progressing steadily. Fullfield and Faversham are held at cost and ASL and RDL have small write-downs.
Iglu.com Holidays continues to perform strongly and is now valued above cost following out-performance of its business plans at the time of investment. DiGiCo, BIH and ATG all experienced increased trading and profitability which has contributed to their higher unrealised valuations. Focus Pharma continues to trade well, although it ended its financial year slightly behind a stretching budget. It launched two new products during 2011 and expects to progress further with several further product launches planned for 2012.
Other companies are still endeavouring to recover from the effects of the continuing downturn. Recovery in the construction and house building sectors remains fragile and this continues to affect the performance of PXP and Plastic Surgeon although Youngman has now fully repaid its bank debt since investment and is well positioned to benefit from any upturn in its markets. Blaze Signs is starting to return improved results demonstrating a strong recovery from the recession.
In March 2011, VSI completed a 50:50 demerger into Lightworks Software Limited and Machineworks Software Limited. As part of the agreement Machineworks assumed all of VSI's loan stock which it repaid in April. The remaining investment in Machineworks in particular is valued considerably above cost.
With effect from 1 October 2008, MPEP assumed responsibility from Foresight for all the investments it managed on behalf of the Company. This section of the portfolio which comprises largely technology and early-stage companies consists of 12 investments with a cost of £8.4 million and valued at £13.2 million as at 30 September 2011 representing 157% of cost (inclusive of the valuation uplift from App-DNA of £10.9 million).
Camwood completed the demerger of its AppDNA business in November 2010. As a result of the demerger, the VCT had two identical investments in each of Camwood Enterprises and App-DNA Group, comprising a 31.5% gross equity stake (28.4% fully diluted). (The original Camwood secured loan of £666,667 has since been repaid by both businesses). Both companies are leading specialists in Application Migration softwareTM. Camwood, trading as Camwood Consulting, provides IT consultancy services to blue chip customers and AppDNA sells its software via third party consultancies. The demerger has established AppDNA as a profitable independent business. App-DNA was realised following the yearend as set out on page 13.
Whilst we remain uncertain about the extent of UK economic recovery, we have been encouraged by developments in the year and we look forward to a productive new investment period. Although the coming months are likely to prove more testing as the public sector cuts begin to take effect and the economy struggles to stabilise its faltering growth, we consider that good quality companies of the calibre in which we seek to invest, capable of maintaining competitive advantage, have the potential to succeed in this environment.
Our caution during the past, challenging investment environment has meant that we now have the cash reserves to deploy on the attractive new investment opportunities that are emerging and support portfolio needs as they arise.
The volatility in the quoted market will inevitably continue to impact on the unrealised valuations of the companies in the portfolio. However, we believe that the portfolio overall is resilient and essentially of high value which will be released in the long-term when the markets return to more stable conditions. Our strategy of investing primarily in MBOs and structuring investments to include loan stock will continue to mitigate downside risk.
Details of the Company's ten largest investments by value as at 30 September 2011 (excluding the four acquisition vehicles in the portfolio which have yet to complete an investment and each have a current cost and valuation of £1 million) are set out on the following pages.
Cost: £180,757 Valuation: £11,633,974 Equity % held: 31.5% Location: London History: Development capital Income in year to I&G: £19,154 Audited financial information:
Basis of valuation: Discounted realisation proceeds Business: Provider of software packaging services
www.app-dna.com
| Year ended | Turnover | Operating profit | Net assets |
|---|---|---|---|
| 31 March 2011 | £7,584,000 | £635,000 | £629,000 |
Cost: £872,625 Valuation: £1,796,667 Basis of valuation: Bid price (AiM-quoted) Equity % held: 2.4% Location: London History: AiM flotation Income in year to I&G: £48,183 Audited financial information:
Business: Development and supply of knowledge management products www.idoxplc.com
| Year ended | Turnover | Operating profit |
Net assets |
Earnings per share |
|---|---|---|---|---|
| 31 October 2010 | £31,268,000 | £7,504,000 | £31,012 | 1.07p |
| Fullfield Limited (Motorclean) | ||
|---|---|---|
| Cost: | £1,718,189 | |
| Valuation: | £1,718,189 | |
| Basis of valuation: | Cost | |
| Equity % held: | 11.7% | |
| Business: | Vehicle cleaning and valet services | www.motorclean.com |
| Location: | Laindon, Essex | |
| History: | Management buy-out | |
| Income in year to I&G: | £35,324 | |
| Audited financial information: | First audited accounts since investment will be for the year ended | |
| 30 November 2011 | ||
| ATG Media Holdings Limited | ||
| Audited financial information: | |||
|---|---|---|---|
| Income in year to I&G: | £92,298 | ||
| History: | Management buy-out | ||
| Location: | London | ||
| Business: | Publisher and on-line auction platform operator | ||
| Equity % held: | 8.5% | ||
| Basis of valuation: | Earnings multiple | www.antiquestradegazette.com | |
| Valuation: | £1,675,368 | ||
| Cost: | £888,993 | ||
| Year ended | Turnover | Operating profit | Net assets |
|---|---|---|---|
| 30 September 2010 | £7,215,000 | £1,261,000 | £2,506,000 |
Operating profit is stated before charging amortisation of goodwill where appropriate for all investee companies.
* Excluding the four acquisition vehicles in the portfolio at 30 September 2011.
Cost: £1,769,790 Valuation: £1,674,630 Basis of valuation: Earnings multiple Equity % held: 9.6% (fully diluted) Location: Cambridge History: Management buy-out Income in year to I&G: £91,216
Business: Provider of printer and photocopier services Audited financial information: First audited accounts since investment will be for the year ended 30 September 2011
Cost: £1,441,667 Valuation: £1,383,792 Basis of valuation: Earnings multiple
Location: Woking, Surrey History: Management buy-out Income in year to I&G: £110,148 Audited financial information:
Equity % held: 13.0% (fully diluted) Business: Recruitment consultants for the pharmaceutical, business intelligence and IT industries
| RDL Corporation Ltd | ||
|---|---|---|
www.rdlcorp.com
| Year ended | Turnover | Operating profit | Net assets |
|---|---|---|---|
| 31 December 2010* | £19,999,000 | £1,111,000 | £2,130,000 |
* Accounts are for the operating subsidiary RDL Recruitment Limited (formerly RDL Corporation Limited
| Cost: | £1,338,500 |
|---|---|
| Valuation: | £1,354,238 |
| Basis of valuation: | Earnings multiple |
| Equity % held: | 12.5% |
| Business: | Manufacturer and installer of signs |
| Location: | Broadstairs, Kent |
| History: | Management buy-out |
| Income in year to I&G: | £97,291 |
| Unaudited financial information: |
f www.blaze-signs.com
| Year ended | Turnover | Operating profit | t Net assets W |
|---|---|---|---|
| 31 March 2011 | £20,127,000 | £1,889,000 | £2,937,000 |
Operating profit is stated before charging amortisation of goodwill where appropriate for all investee companies.
Cost: £325,594 Valuation: £1,258,330 Basis of valuation: Earnings multiple Equity % held: 4.3% Location: Chessington, Surrey History: Management buy-out Income in year to I&G: £94,308 Audited financial information:
Business: Designer and manufacturer of digital audio mixing desks
| Year ended | Turnover | Operating profit | Net assets |
|---|---|---|---|
| 31 December 2010 | £18,757,000 | £5,501,000 | £8,909,000 |
Cost: £1,000,000 Valuation: £1,025,448 Basis of valuation: Earnings multiple Equity % held: 6.0%
Business: Importer and distributor of artificial flowers, floral sundries and home décor products
www.digico.org
www.countrybaskets.co.uk
| Year ended | Turnover | Operating profit | Net assets |
|---|---|---|---|
| 31 December 2010 | £21,197,000 | £2,139,000 | £4,259,000 |
| Westway Services Holdings (2010) Limited | ||||
|---|---|---|---|---|
| Cost: | £353,589 | |||
| Valuation: | £928,577 | |||
| Basis of valuation: | Earnings multiple | |||
| Equity % held: | 4.7% | www.westwaycooling.com | ||
| Business: | Installation, service and maintenance of air conditioning systems | |||
| Location: | Greenford, Middlesex | |||
| History: | Management buy-out | |||
| Income in year to I&G: | £34,995 | |||
| Audited financial information: | ||||
| Year ended | Turnover | Operating profit | Net assets |
The remaining 35 investments in the portfolio (including the four acquisition vehicles in the portfolio at 30 September 2011) had a current cost of £19.7 million and were valued at 30 September 2011 at £12.7 million.
28 February 2011 £27,521,000 £3,942,000 £3,769,000
Further details of the investments in the portfolio may be found on MPEP's website: www.matrixpep.co.uk
Operating profit is stated before charging amortisation of goodwill where appropriate for all investee companies.
| Investment Portfolio Summary |
|---|
| as at 30 September 2011 |
|---|
| Ordinary Shares | Other Investments | 1 | Total | Total | Total | Interest | Dividends | Unrealised | Realised | Gross | % of | % of | Description of loan | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-11 Cost at |
Valuation at 30-Sep-11 |
Cost at 30-Sep-11 |
Valuation at 30-Sep-11 |
Cost at 30-Sep-11 |
Valuation at 30-Sep-10 |
Additional investments |
Valuation at receivable 30-Sep-11 |
in period | receivable gains/(losses) in period |
in period | gains in period |
proceeds | held 2 3 equity |
portfolio by value |
stock | |
| 4 App-DNA Group Limited |
£ 166,667 |
£ 11,619,884 |
£ 14,090 |
£ 14,090 |
£ 180,757 |
£ 1,091,346 |
£ - |
£ 11,633,974 |
£ 19,154 |
£ - |
£ 10,875,962 |
£ - |
£ 333,334 |
31.5% | 31.31% | |
| Provider of software repackaging services | ||||||||||||||||
| 5 I-Dox plc |
872,625 | 1,796,667 | - | - | 872,625 | 939,167 | - | 1,796,667 | - | 48,183 | 857,500 | - | - | 2.4% | 4.83% | - |
| Developer and supplier of knowledge management products Fullfield Limited (trading as Motorclean) |
544,093 | 544,093 | 1,174,096 | 1,174,096 | 1,718,189 | 1,000,000 | 718,189 | 1,718,189 | 35,324 | - | - | - | - | 11.7% | 4.61% | Secured variable loan |
| Vehicle cleaning and valet services | 2016 | |||||||||||||||
| ATG Media Holdings Limited | 355,660 | 1,035,591 | 533,333 | 639,777 | 888,993 | 1,377,208 | 104 | 1,675,368 | 53,222 | 39,076 | 409,167 | - | 111,111 | 8.5% | 4.51% | Secured loan stock 2013 at 10.0% |
| ASL Technology Holdings Limited (formerly Apricot Trading Limited) Publisher and online auction platform operator |
418,321 | - | 1,351,469 | 1,674,630 | 1,769,790 | 1,000,000 | 769,790 | 1,674,630 | 91,216 | - | (95,160) | - | - | 9.6% | 4.51% | Secured loan at 10% 2015 |
| Printer and photocopier services | and 2016 | |||||||||||||||
| RDL Corporation Limited (formerly Aust Recruitment Group Limited) Recruitment provider within the pharmaceutical, business intelligence |
250,752 | 147,820 | 1,190,915 | 1,235,972 | 1,441,667 | 1,000,000 | 441,667 | 1,383,792 | 110,148 | - | (57,875) | - | - | 13.0% | 3.72% | Secured variable loan 2012 |
| Blaze Signs Holdings Limited and IT sectors |
401,550 | 141,222 | 936,950 | 1,213,016 | 1,338,500 | 242,090 | - | 1,354,238 | 97,291 | - | 1,112,148 | - | - | 12.5% | 3.64% | Secured loan stock 2011 |
| Manufacturer and installer of signs DiGiCo Europe Limited |
253,906 | 1,181,325 | 71,688 | 77,005 | 325,594 | 1,201,553 | - | 1,258,330 | 5,441 | 88,867 | 56,777 | - | - | 4.3% | 3.39% | Secured loan stock 2012 and 2012 at 10% |
| Designer and manufacturer of digital audio mixing desks | at 10.75% | |||||||||||||||
| Importer and distributor of artificial flowers, floral sundries and home CB Imports Group Limited (trading as Country Baskets) decor products |
175,000 | 25,448 | 825,000 | 1,000,000 | 1,000,000 | 1,199,310 | - | 1,025,448 | 72,023 | 9,512 | (173,862) | - | - | 6.0% | 2.76% | Secured loan stock 2014 at 8.73% |
| Company seeking to acquire businesses in the food manufacturing, Backbarrow Limited |
400,000 | 400,000 | 600,000 | 600,000 | 1,000,000 | 1,000,000 | - | 1,000,000 | - | - | - | - | - | 16.7% | 2.70% | Secured variable loan 2013 |
| distribution and brand management sectors | ||||||||||||||||
| Company seeking to acquire businesses in the brand management, Bladon Castle Management Limited consumer products and retail sectors |
400,000 | 400,000 | 600,000 | 600,000 | 1,000,000 | 1,000,000 | - | 1,000,000 | - | - | - | - | - | 16.7% | 2.70% | Secured variable loan 2013 |
| Rusland Management Limited | 400,000 | 400,000 | 600,000 | 600,000 | 1,000,000 | 1,000,000 | - | 1,000,000 | - | - | - | - | - | 16.3% | 2.70% | Secured variable loan |
| Company seeking to acquire businesses in the brand management, consumer products and retail sectors |
2013 | |||||||||||||||
| Torvar Limited | 400,000 | 400,000 | 600,000 | 600,000 | 1,000,000 | 1,000,000 | - | 1,000,000 | - | - | - | - | - | 16.3% | 2.70% | Secured variable loan 2013 |
| Company seeking to acquire businesses in the database management, mapping, data mapping and management services sectors |
||||||||||||||||
| Installation, service and maintenance of air conditioning systems Westway Services Holdings (2010) Limited |
57,941 | 498,619 | 295,648 | 429,958 | 353,589 | 884,557 | - | 928,577 | 34,995 | - | 143,701 | - | 99,681 | 4.7% | 2.50% | Secured loan stock 2014 at 10.7% |
| Iglu.com Holidays Limited | 150,000 | 886,331 | 2,326 | 2,326 | 152,326 | 1,616,116 | - | 888,657 | 24,153 | - | 270,215 | 1 | 997,675 | 8.1% | 2.39% | |
| Online ski and cruise travel agency Youngman Group Limited |
100,052 | - | 900,000 | 682,203 | 1,000,052 | 700,992 | - | 682,203 | 59,175 | 1,429 | (18,789) | - | - | 8.5% | 1.84% | Secured loan stock 2010 |
| Manufacturer of ladders and access towers | at 8.5% | |||||||||||||||
| British International Holdings Limited Helicopter service operator |
112,500 | - | 478,409 | 646,718 | 590,909 | 796,381 | - | 646,718 | 10,939 | - | (149,663) | - | - | 5.0% | 1.74% | Secured loan stock 2011 at 9% and 2014 at 12% |
| Focus Pharma Holdings Limited | 180,914 | 142,292 | 335,986 | 486,414 | 516,900 | 707,569 | - | 628,706 | 36,769 | 6,057 | (78,863) | - | - | 2.1% | 1.69% | Secured loan stock 2012 at 10.97% |
| Licensor and distributor of generic pharmaceuticals Brookerpaks Limited |
50,000 | 571,042 | 5,000 | 5,000 | 55,000 | 498,095 | - | 576,042 | - | 132,957 | 77,947 | - | - | 18.2% | 1.55% | - |
| Importer and distributor of garlic and vacuum-packed vegetables 10 |
Unsecured loan stock | |||||||||||||||
| Sale of false nails, nail accessories, false eyelashes, depilatory products, Original Additions Topco Limited hair lightening and perming products |
- | - | 25,696 | 537,948 | 25,696 | - | - | 537,948 | 8,725 | - | - | - | - | 0.0% | 1.45% | 2018 at 8% |
| Duncary 8 Limited | 126,590 | 27,366 | 508,333 | 508,333 | 634,923 | 683,746 | - | 535,699 | 10,028 | - | (148,047) | - | - | 25.5% | 1.44% | Secured loan stock 2015 at 2% |
| 4 Camwood Enterprises Limited Technical training business |
166,667 | 485,092 | 14,090 | 14,090 | 180,757 | 1,091,346 | - | 499,182 | 12,881 | - | (258,831) | - | 333,334 | 31.5% | 1.34% | |
| Publisher, exhibition organiser and operator of websites for the Provider of software repackaging services Faversham House Holdings Limited |
185,060 | 185,060 | 302,684 | 302,684 | 487,744 | - | 487,744 | 487,744 | 30,683 | - | - | - | - | 8.8% | 1.31% | Secured loan stock 2015 at 12.50% |
| Manufacturing and marketing of bespoke electron beam welding and environmental, visual communications and building services 6 Aquasium Technology Limited |
166,667 | - | 533,333 | 486,319 | 700,000 | 396,581 | - | 486,319 | - | - | 89,738 | - | - | 16.7% | 1.31% | 2006 and at 7% 2008 and Secured loans at 8.25% 2010 |
| vacuum furnace equipment 5 Tikit Group plc |
189,500 | 458,094 | - | - | 189,500 | 839,129 | - | 458,094 | - | 13,356 | 140,064 | 106,901 | 628,000 | 1.1% | 1.23% | - |
| Supplier of IT solutions and support services to legal and accounting businesses |
||||||||||||||||
| Provider of software for CAD and CAM vendors 7 Machineworks Software Limited |
20,471 | 407,310 | - | - | 20,471 | 583,453 | - | 407,310 | 10,429 | 12,947 | 8,557 | 10,234 | 255,818 | 9.2% | 1.10% | - |
| Omega Diagnostics Group plc | 279,996 | 291,663 | - | - | 279,996 | - | 279,996 | 291,663 | - | - | 11,667 | - | - | 2.7% | 0.78% | - |
| In-vitro diagnostics for food intolerance, autoimmune diseases and infectious diseases |
| Ordinary Shares | Other Investments | 1 | Total | Total | Total | Interest | Dividends | Unrealised | Realised | Proceeds | % of | % of | Description of loan | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost at 30-Sep-11 |
Valuation at 30-Sep-11 |
30-Sep-11 Cost at |
Valuation at 30-Sep-11 |
Cost at 30-Sep-11 |
Valuation at 30-Sep-10 |
Additional investments |
Valuation at receivable 30-Sep-11 |
in period | in period | receivable gains/(losses) in period |
gains in period |
held 2 3 equity |
portfolio by value |
stock | ||
| Image Source Group Limited | £ 300,000 |
£ 233,977 |
£ 5,000 |
£ 5,000 |
£ 305,000 |
£ 1,399,114 |
£ - |
£ 238,977 |
£ - |
£ - |
£ (1,160,137) |
£ - |
£ - |
44.0% | 0.64% | - |
| Royalty free picture library Letraset Limited |
450,010 | 34,385 | 200,000 | 200,000 | 650,010 | 213,859 | 10 | 234,385 | - | - | 20,516 | - | - | 5.3% | 0.63% | Unsecured subordinated loan stock 2009 at 8% |
| Manufacturer and worldwide distributor of graphic art products 6 Alaric Systems Limited |
565,156 | 136,467 | 30,646 | 30,647 | 595,802 | 30,647 | - | 167,114 | - | - | 136,467 | - | - | 6.9% | 0.44% | Secured variable rate loan stock 2009 |
| Software developer and provider of support services for retail credit card payment systems |
||||||||||||||||
| 8 NexxtDrive Limited |
487,014 | - | 325,000 | 162,500 | 812,014 | 162,500 | - | 162,500 | - | - | (7,901) | - | - | 6.2% | 0.43% | Secured convertible loan stock at 10% 2011 |
| Developer and exploiter of mechanical transmission technologies Racoon International Holdings Limited |
165,256 | - | 385,596 | 157,755 | 550,852 | 243,664 | - | 157,755 | - | (85,909) | - | - | 7.7% | 0.42% | Secured loan stock 2011 at 12% |
|
| Supplier of hair extensions, hair care products and training 6 ANT plc |
462,816 | 144,451 | - | - | 462,816 | 160,866 | - | 144,451 | - | - | (16,415) | - | - | 2.7% | 0.39% | - |
| Provider of embedded browser/email software for consumer electronics Vectair Holdings Limited and Internet appliances |
53,207 | 138,932 | 193 | 193 | 53,400 | 366,575 | - | 139,125 | 9,257 | - | (32,433) | - | 195,017 | 4.6% | 0.37% | |
| Designer and distributor of washroom products The Plastic Surgeon Holdings Limited |
40,610 | - | 365,472 | 101,521 | 406,082 | 101,521 | - | 101,521 | 28,491 | - | - | - | - | 6.1% | 0.27% | Secured loan stock 2013 |
| Supplier of snagging and finishing services to the property sector 6 Oxonica Limited (formerly Oxonica plc) |
2,524,527 | 69,624 | - | - | 2,524,527 | - | - | 69,624 | - | - | 69,624 | 69,624 | 69,624 | 10.6% | 0.19% | at 8.62% - |
| International nanomaterials group 7 Lightworks Software Limited |
20,471 | 54,138 | - | - | 20,471 | 194,484 | - | 54,138 | - | 12,947 | (79,462) | - | - | 9.2% | 0.15% | - |
| Supplier of engineering services to the water and waste sectors Provider of software for CAD and CAM vendors Monsal Holdings Limited |
145,314 | - | 323,296 | 42,446 | 468,610 | 768,505 | 42,446 | 42,446 | 6,102 | - | (768,505) | - | - | 5.6% | 0.11% | Secured loan stock 2012 at 8.62% and variable |
| Developer and manufacturer of antennae for mobile phones and other 6 Sarantel Group plc wireless devices |
1,881,252 | 39,485 | - | - | 1,881,252 | 102,117 | - | 39,485 | - | - | (62,632) | - | - | 0.8% | 0.11% | loans 2016 - |
| (Formerly Corero plc) Provider of e-business technologies 6 Corero Network Security plc |
600,000 | 35,363 | - | - | 600,000 | 24,558 | - | 35,363 | - | - | 10,805 | - | - | 0.2% | 0.10% | - |
| PXP Holdings Limited (Pinewood Structures) | 227,783 | - | 692,393 | - | 920,176 | - | - | - | - | - | - | - | - | 6.8% | - | Secured loan stock 2012 and 2013 at 8% |
| Designer, manufacturer and supplier of timber frames for buildings 6 Aigis Blast Protection Limited |
272,120 | - | - | - | 272,120 | - | - | - | - | - | - | - | - | 0.4% | - | - |
| Provider of manned guarding, mobile patrols and alarm response Specialist blast containment materials company Legion Group plc (in administration) |
150,000 | - | - | - | 150,000 | - | - | - | - | - | - | - | - | 0.7% | - | - |
| 8 Biomer Technology Limited services |
137,170 | - | - | - | 137,170 | 226,152 | - | - | - | - | (226,152) | - | - | 4.4% | - | - |
| Developer of biomaterials for medical devices 6 DCG Group Limited |
83,324 | - | - | - | 83,324 | 181,771 | - | - | 19,636 | - | - | 30,902 | 204,772 | 10.7% | - | |
| Design, supply and integration of data storage solutions 9 Other investments in the portfolio |
- | - | - | - | - | - | - | - | - | - | - | 6,839 | 6,839 | - | - | |
| 10 Amaldis (2008) Limited (Original Additions) Disposed in year |
- | - | - | - | - | 1,965,586 | - | - | 426,713 | - | - | 38,047 | 1,465,685 | 0.0% | - | |
| Manufacturer and distributor of beauty products Campden Media Limited |
- | - | - | - | - | 125,921 | - | - | - | - | - | 161,318 | 287,239 | 0.0% | - | |
| HWA Group Limited (Holloway White Allom) (in administration) High value property restoration and refurbishment Magazine publisher and conference organiser |
- | - | - | - | - | - | - | - | - | - | - | 49,341 | 49,340 | 0.0% | - | - |
| Total | 15,390,962 | 22,931,741 | 14,226,642 | 14,230,641 | 29,617,604 | 28,116,479 | 2,739,946 | 37,162,382 | 1,212,795 | 365,331 | 10,870,219 | 473,207 | 5,037,469 | 100.00% |
3
5
6
9
10
1 'Other investments' comprise principally loan stock instruments, and/or relatively small amounts of preference shares. 2 The percentage of equity held, and the amounts co-invested, in these companies by funds managed by Matrix Private Equity Partners LLP are disclosed in Note 14 to the financial statements. The percentage of equity held for these companies may be subject to further dilution of an additional 1% or more if, for example, management of the investee company exercises share options.
4 On 28 March 2011, Camwood Limited was demerged resulting in a 50:50 split holding in App-DNA Group Limited and Camwood Enterprises Limited
Investment formerly managed by Nova Capital Management Limited until 31 August 2007.
Investment formerly managed by Foresight Group up to various dates ending on or before 10 March 2009.
7 On 31 March 2011, VSI Limited (VSI) undertook a demerger, such that the Company now holds separate investments in Machineworks Software Limited (Machineworks) and Lightworks Software Limited (Lightworks). On the demerger date, the cost of the ordinary shares and the cost and valuation of the preference share investments were split equally between Machineworks and Lightworks. However the valuation of the ordinary share investments at the merger date was split 75:25 between Machineworks and Lightworks respectively. The former loan investment in VSI of £255,818 was wholly transferred to Machineworks at the date of the Merger. It was repaid in full on 4 April 2011.
8 Investment formerly managed by Nova Capital Management Limited until 31 August 2007 and by Foresight Group until various dates ending on or before 10 March 2009.
'Other investments in the portfolio' comprises Stortext-FM Limited/Stortext (DO) Limited which was sold during the year and Frozen Herbs Limited (a subsidiary of FH Ingredients Limited which was dissolved in 2008).
As part of the consideration on the disposal of Amaldis (2008) Limited, £537,948 of Original Additions Topco Limited loan stock was issued to the Company.
Status: Independent Non-Executive Chairman Age: 69
Date of appointment: 13 October 2000
Qualifications: MA
Experience: Colin has wide financial and commercial experience. He has worked in the City for more than thirty years. During this time he directed fund management operations for more than ten years. His City involvement includes mergers and acquisitions and flotations. From 1994 to 1997 he was Chief Executive of Ivory and Sime plc. He is currently the Chief Executive of Pole Star Space Applications Limited, a leading provider of real-time tracking information for maritime applications via a global web-based satellite enabled solution. Until September 2010, he was the non-executive chairman and a director of Matrix Income and Growth 4 VCT plc.
Last re-elected to the Board: February 2011. Standing for re-election at the AGM in 2012. Committee memberships: Nominations and Remuneration Committee (Chairman to 5 December 2011), Audit Committee, Investment Committee.
Number of Board and Committee meetings attended 2010/11: 13/13.
Remuneration 2010/11: £41,000.
Relevant relationships with the Investment Manager or other service providers: None Shared directorships with other I&G Directors: None
Shareholding in the Company: 38,997 Ordinary Shares.
Status: Independent Non-Executive Director
Age: 58
Date of appointment: 1 August 2010
Qualifications: Fellow of the Institute of Chartered Accountants in England and Wales BSc (Engineering Sciences)
Experience: Jonathan qualified as a Chartered Accountant. He has significant experience of the investment trust sector and of serving on the boards of both public and private companies in executive and non-executive roles. Jonathan joined Caledonia Investments plc in 1989, serving as Finance Director from 1991 to December 2009. Prior to this he was Group Financial Controller at Hanson plc 1984 - 1989. He was a non-executive Director of Bristow Group Inc. (1996 – 2009) and has been a non-executive director of Serica Energy plc (from 2008 to date), British Portfolio Trust plc (from September 2010) and Aberforth Geared Income Trust plc (from March 2010). Jonathan has served on the Self-Managed Investment Trust Committee of the Association of Investment Companies (to December 2009).
Elected to the Board: February 2011.
Committee memberships: Audit Committee (Chairman), Investment Committee, Nominations and Remuneration Committee.
Number of Board and Committee meetings attended 2010/11: 12/12
Remuneration 2010/11: £31,000.
Relevant relationships with the Investment Manager or other service providers: None.
Relevant relationships with investee companies: None.
Shared directorships with other I&G Directors: None.
Shareholding in the Company: 7,016 Ordinary Shares.
Status: Non-Executive Director Age: 45 Date of appointment: 29 January 2003 Qualifications: MA, MBA
Experience: Helen has extensive experience of investing in a wide range of small and medium sized businesses. She graduated in economics from Cambridge University and began her career in banking. After an MBA at INSEAD business school, Helen worked from 1991 to 1998 at 3i plc based in their London office. She was a founding director of Matrix Private Equity Limited when it was established in early 2000 and has since raised two funds, Matrix Income & Growth 2 VCT plc and Matrix Enterprise Fund. After leaving Matrix in 2005, she was a non-executive director of Hotbed Fund Managers Limited from 2006-08. She is Chairman of British Smaller Companies VCT plc, a non-executive director of Matrix Income & Growth 4 VCT plc, Framlington AIM VCT plc, Octopus Eclipse VCT 3 PLC and Spark Ventures plc.
Last re-elected to the Board: February 2011. Standing for re-election at the AGM in 2012 Committee memberships: Investment Committee (Chairman), Audit Committee, Nominations and Remuneration Committee (Chairman from 5 December 2011). Number of Board and Committee meetings attended 2010/11: 12/12.
Remuneration 2010/11: £31,000.
Relevant relationships with the Investment Manager or other service providers: Matrix Income & Growth 4 VCT plc is also managed by MPEP.
Shared directorships with other I&G Directors: None
Shareholding in the Company: 15,883 Ordinary Shares.
The Directors present the eleventh Annual Report and Accounts of the Company for the year ended 30 September 2011.
The principal activity of the Company during the year under review was investment in unquoted or AiM-quoted companies in the United Kingdom. Details of the principal investments made by the Company are given in the Investment Manager's Review and Investment Portfolio Summary on pages 13 - 24 of this Annual Report.
The ordinary shares ("formerly 'S' Shares") were first admitted to the Official List of the UK Listing Authority ("UKLA") and to trading 8 February 2008. Following the merger of the former classes of 'O' (first admitted to the Official List of the UKLA and to trading on 15 November 2000) and 'S' Shares, detailed below, the listing of the 'S' Shares was amended on the Official List to ordinary shares of 1p in the capital of the Company ("Ordinary Shares") on 30 March 2010 and the 'O' Share listing was cancelled.
The Company has satisfied the requirements for full approval as a Venture Capital Trust under section 274 of the Income Tax Act 2007 ("the ITA"). It is the Directors' intention to continue to manage the Company's affairs in such a manner as to comply with section 274 of the ITA.
The Company revoked its status as an investment company on 30 November 2005 as defined by section 266 of the Companies Act 1985 ("the 1985 Act") subsequently superseded by section 833 of the Companies Act 2006 ("the 2006 Act") and does not intend to re-apply for such status.
The objective of the Directors continues to be to provide investors with an attractive return by maximising the stream of dividend distributions from the income and capital gains generated by a diverse and carefully selected portfolio of investments.
The Directors intend to continue their policy of investing in companies at various stages of development. In some instances this will include investments in new and secondary issues of companies which may already be quoted on AiM or PLUS.
For a review of the Company's development and performance during the year and future prospects, please see the Chairman's Statement on pages 5 - 10 and the Investment Manager's Review and Investment Portfolio Summary on pages 13 - 24 of this Report. The Financial Highlights on pages 1 - 3 provides data on the Company's key performance indicators.
The Company's Investment Policy on pages 11 - 12 provides information on the Company's financial risk management objectives and exposure to risks.
The Board reviews performance by reference to various measures, taking account of the long term nature of the assets in which the Company invests.
The total return per share is the key measure of performance for the Company which comprises NAV plus cumulative dividends paid per share. NAV is calculated quarterly in accordance with the International Private Equity Venture Capital Valuation (IPEVCV) guidelines. The VCT's net assets increased during the year under review resulting in a 25.9% rise in total return per share.
For further information on the relative performances of the two former Share Funds please see the Financial Highlights on pages 1 - 3.
The TER of the Company for the year under review was 2.7%. Under the terms of the Investment Advisers' Agreement, annual expenses, excluding any exceptional items, Investment Manager's performance fee and trail commission, are capped at 3.25% of closing net assets. Any expenses in excess of the 3.25% cap are borne by the Investment Manager and the Promoter. Removing these exceptional items and trail commission from the TER reduces the figure to 2.5% and therefore £nil was repayable this year (2010: £nil). The above figures exclude the litigation costs disclosed in Note 5.
The Board believes that the principal risks faced by the Company are:
• Regulatory risk the Company is required to comply with the Companies Act 2006 ("the Companies Act"), the listing rules of the UKLA and United Kingdom Accounting Standards. Breach of any of these might lead to suspension of the Company's Stock Exchange listing, financial penalties or a qualified audit report.
• Financial and operating risk inadequate controls that might lead to misappropriation of assets. Inappropriate accounting policies might lead to misreporting or beaches of regulations. Failure of the Investment Manager's and Administrator's accounting systems or disruption to its business might lead to an inability to provide accurate reporting and monitoring.
The Board seeks to mitigate the internal risks by setting policy and by undertaking a key risk management review at each quarterly Board meeting. Performance is regularly reviewed and assurances in respect of adequate internal controls and key risks are sought and received from the Investment Manager and Administrator on a six monthly basis. In mitigation and the management of these risks, the Board applies rigorously the principles detailed in the AIC Code of Corporate Governance. The Board also has a Share Buy-Back policy which seeks to mitigate the Market Liquidity risk. This policy is reviewed at each quarterly Board Meeting.
During the year under review, the Company issued a total of 5,370,922 ordinary shares. Of this total 5,239,609 (2010: nil) ordinary shares were issued under the Matrix VCT Linked Offer for Subscription launched on 12 November 2010 and 131,313 ordinary shares (2010: 112,768 former 'O' Shares; 6,674 former 'S' Shares) were issued under the Company's Dividend Investment Scheme.
The Board believes that it is in the best interests of the Company and its Shareholders for the Company to make market purchases of its shares to seek both to enhance net asset value and to discourage excessive discounts to market prices quoted. An Authority for the Company to purchase its own shares pursuant to section 701 of the Companies Act was in place throughout the year under review. For further details please see Note 16 to the accounts on pages 66 - 67 of this Annual Report. A resolution to renew this authority will be proposed at the Annual General Meeting to be held on 9 February 2012.
During the year the Company bought back 1,649,765 of its own Ordinary Shares (2010: 1,037,821 Ordinary Shares plus 369,937 former 'O' Shares bought-back prior to the Merger on 29 March 2010) representing 4.5% of the Ordinary Shares in issue at the beginning of the year (2010: Ordinary shares in the six months following the merger: 2.7% of the shares in issue on the date of Merger; former 'O' Shares in the six months up until the date of the Merger: 1.1% of the 'O' Shares in issue at 1 October 2010) at a cost of £1,475,019 (2010: £966,118).
The shares bought back were subsequently cancelled by the Company.
The issued Ordinary Share capital of the Company as at 30 September 2011 was £406,920 (2010: £369,709) and the number of Ordinary Shares in issue as at this date was 40,692,048 (2010: 36,970,891).
The basic revenue return after taxation attributable to Shareholders for the period was £864,072 (2010: loss of £50,860).
An interim capital dividend of 20 pence per Ordinary Share will be paid in respect of the year ending 30 September 2012 on 27 January 2012 to Shareholders on the Register on 30 December 2011.
The Directors are recommending a final dividend of 4 pence per Ordinary Share comprising 2 pence from capital and 2 pence from income in respect of the year ended 30 September 2011. The dividend will be proposed to Shareholders at the Annual General Meeting of the Company to be held on 9 February 2012 and paid to Shareholders on the Register on 20 January 2012, on 15 February 2012.
An interim capital dividend of 2 pence per share and a final dividend of 2 pence per shares were paid to shareholders during the year in respect of the year ended 30 September 2010.
The Company's Dividend Investment Scheme ("the Scheme") will apply to the special interim dividend and the final dividends and elections under the Scheme should be received by the Scheme Administrator, Capita Registrars, no later than 12 January 2012 in the case of the special dividend and 31 January 2012 in the case of the final dividends.
The names of the Directors appear below and on pages 25 - 26 of this Annual Report.
The Directors' interests in the issued Ordinary Shares of the Company as at 30 September 2011 were:
| Ordinary Shares | Ordinary Shares | |
|---|---|---|
| held on 30 September 2011 | held on 30 September 2010 | |
| Director | ||
| Colin Hook | 38,997 | 30,587 |
| Jonathan Cartwright | 7,016 | - |
| Helen Sinclair | 15,883 | 10,605 |
During the year under review, each of the Directors were allotted the following shares under the Matrix VCTs Linked Offer and the Company's Dividend Investment Scheme:
| Shares allotted under the Matrix VCTs Linked Offer |
Shares allotted under the Company's Dividend Investment Scheme |
Total shares allotted to each Director during the year |
|
|---|---|---|---|
| Director | |||
| Colin Hook | 6,711 | 1,699 | 8,410 |
| Jonathan Cartwright | 6,711 | 305 | 7,016 |
| Helen Sinclair | 5,033 | 245 | 5,278 |
There have been no further changes to the Directors' share interests between the year-end and the date of this Annual Report.
In accordance with the AIC Code, Colin Hook, who has served on the Board for 11 years, has agreed to retire annually from the Board and, being eligible, offers himself for reelection at the forthcoming Annual General Meeting. The Board confirms that, following a review of his performance, Colin Hook continues to make a substantial contribution to the Board as its Chairman and that his length of service is an asset to the Company. The remaining directors have no hesitation in recommending his re-election to Shareholders.
With the exception of Helen Sinclair, all the Directors are considered to be independent of the Investment Manager. Helen Sinclair also sits on the Board of Matrix Income & Growth 4 VCT plc, which is also managed by Matrix Private Equity Partners, and as such she is not considered to be independent of the Manager and has agreed to retire annually from the Board. In accordance with the AIC Code, and being eligible, she will offer herself for reelection at the forthcoming Annual General Meeting. The Board confirms that, following a review of her performance, Helen Sinclair has considerable experience both of making investments in the types of companies in which the VCT invests and of being a VCT director. She has shown herself to be a committed and independent director who continues to make a substantial contribution to the Board as Chairman of the Investment Committee. The remaining directors have no hesitation in recommending her re-election to Shareholders.
Biographical notes on these Directors are given on pages 25 - 26 of this Annual Report.
Copies of the Directors' appointment letters shall be available for inspection at the place of the Annual General Meeting for at least fifteen minutes prior to and during the meeting. The Directors do not have any service contracts with the Company.
It is the policy of the Directors not to participate in decisions concerning investee companies in which they hold an interest. None of the Directors held interests in investee companies throughout the year.
No options over the share capital of the Company have been granted to the Directors. The Company does not have any employees.
Matrix Private Equity Partners LLP (MPEP) acts as Investment Manager and provides administrative and company secretarial services to the Company.
The Board reviews annually, and at other times as and when necessary, the Investment Management Agreement and the performance of the Investment Manager, and the other service providers including the auditors, VCT status adviser, solicitors, bankers and registrars. Particular emphasis is placed on reviewing the Investment Manager, in terms of investment performance, quality of information provided to the Board and remuneration. This work forms part of the Board's overall internal control procedures as discussed elsewhere. As part of this review the Board considers the quality and continuity of the investment management team, the investment process and the results achieved to date. The Board places significant emphasis on the Company's performance against benchmarks and is satisfied that the VCT's performance remained ahead of the benchmark used on a consistent basis. The Board further considered the Manager's commitment to the promotion of the Company and was satisfied that this was prioritised highly by the Manager as evidenced by the Matrix Linked VCT fundraisings in 2010/11 and 2011/12 with other MPEP managed VCTs.
The principal terms of the Company's Investment Manager's Agreement with the Manager dated 29 March 2010 and the previous contractual arrangements prior to this date are set out in Note 3 to the Accounts on pages 57 - 58 of this Annual Report. Having considered the terms of this agreement, and where relevant those of companies in the same peer group, the Board considers that the terms of this agreement represents an appropriate balance between cost and incentivisation of the Manager.
The continued appointment of Matrix Private Equity Partners on the existing terms was approved by the Board on 27 September 2011. The Directors believe that the continuing appointment of MPEP as the Investment Manager on the terms currently agreed is in the interests of its Shareholders.
MPEP also acts as both Company Administrator and Company Secretary under the terms of the agreement.
Each shareholder has one vote on a show of hands, and on a poll one vote per share held, at a general meeting of the Company. No member shall be entitled to vote or exercise any rights at a general meeting unless all shares have been paid up in full. Any instrument of proxy must be deposited at the place specified by the directors no later than 48 hours before the time for holding the meeting.
Shareholders may, if they so wish, arrange for their shares to be held via a nominee or depository where they retain the financial rights carried by the Company's shares.
The Company has retained PricewaterhouseCoopers LLP to advise on its compliance with the tax legislative requirements relating to VCTs. As such, they advise on compliance with requirements of the venture capital trust tax legislation on the basis of information provided by Matrix Private Equity Partners. Matrix Private Equity Partners also seeks professional advice in relation to the application of the venture capital trust legislation to any company in which the Company is proposing to invest. The Directors monitor the continuing tests for the Company's VCT status at Board meetings.
PKF (UK) LLP were re-appointed as auditor during the year. Resolutions to re-appoint PKF (UK) LLP as auditor to the Company and to authorise the Directors to determine its remuneration will be proposed at the Annual General Meeting.
So far as the Directors in office at 30 September 2011 are aware, there is no relevant audit information of which the auditors are unaware. They have individually taken all the steps that they ought to have taken as Directors in order to make themselves aware of any relevant audit information and to establish that the Company's auditor is aware of that information.
As at the date of this report the Company had not been notified of any beneficial interest exceeding 3% of the issued share capital.
The main risks arising from the Company's financial instruments are due to fluctuations in the market price and interest rates, credit risk and liquidity risk. The Board regularly reviews and agrees policies for managing these risks and full details can be found in Note 20 to the Accounts on pages 67 - 74 of this Annual Report.
The VCT has adopted a zero tolerance approach to bribery. The following is a summary of its policy:
The Company's policy is to pay all creditors' invoices within 30 days of the invoice date unless otherwise agreed. At the year-end trade creditors were £22,704 (2010: £33,262). At 30 September 2011 the average credit period for trade creditors was 4 days (2010: 7 days).
The Board seeks to conduct the Company's affairs responsibly and considers relevant social and environmental matters when appropriate, particularly with regard to investment decisions. The Company uses mixed sources paper from well-managed forests and recycled wood and fibre as endorsed by the Forest Stewardship Council for the printing of its Circulars and Annual and Half-Yearly Reports.
The Company maintains a Directors' and Officers' liability insurance policy. The policy does not provide cover for fraudulent or dishonest actions by the Directors.
Notice of the Annual General Meeting to be held on 9 February 2012 is set out on pages 76 - 78 of this Annual Report.
The following is an explanation of resolutions 8 to 10, which together with resolutions 1 to 7 form the business to be proposed at the meeting. Resolutions 1 to 8 will be proposed as ordinary resolutions requiring more than 50% of the votes cast at the meeting to be in favour and resolutions 9 and 10 will be proposed as special resolutions requiring the approval of 75% of the votes cast at the meeting.
The Directors believe that the proposed resolutions are in the interests of Shareholders and accordingly recommend Shareholders to vote in favour of each resolution.
These two resolutions grant the Directors the authority to allot Ordinary Shares for cash to a limited and defined extent otherwise than pro rata to existing Shareholders.
Resolution 8 will enable the Directors to allot new shares up to an aggregate nominal amount not exceeding £380,000 representing approximately 93.3% of the issued share capital of the Company as at the date of the notice of the meeting. The authority granted by this resolution will expire on the fifth anniversary of the date of the passing of this resolution.
Under section 561(1) of the 2006 Act, if the Directors wish to allot new shares or sell treasury shares for cash they must first offer such shares to existing Shareholders in proportion to their current holdings. It is proposed by Resolution 9 to sanction the disapplication of such pre-emption rights in respect of the allotment of equity securities (i) with an aggregate nominal value of £300,000 in connection with offer(s) for subscription; (ii) with a nominal value of up to 10% of the issued share capital of the Company from time to time pursuant to any dividend investment scheme operated by the Company; and (iii) with a nominal value of up to 10% of the issued share capital of the Company from time to time. The proceeds of these allotments may be used in whole or part to purchase the Company's Shares.
Resolution 9 will expire on the conclusion of the Annual General Meeting of the Company to be held in 2013.
In accordance with an authority approved by Shareholders at the Annual General Meeting of the Company held on 16 February 2011, the Directors are authorised to allot shares pursuant to the Company's Dividend Investment Scheme at their mid market price, even if this is less than net asset value per share.
The Directors may allot securities after the expiry dates given above in pursuance of offers or agreements made prior to the expiration of these authorities. Both resolutions generally renew previous authorities approved at the annual general meeting of the Company held on 16 February 2011.
The Directors intend to launch a joint Offer for Subscription with Matrix Income & Growth VCT plc and Matrix Income & Growth 4 VCT plc in January 2012 to raise up to £7 million for each VCT and it is the Directors' intention that new shares may be issued pursuant to the Offer under this authority (to the extent that existing authorities do not apply). It is further intended to allot shares under the Dividend Investment Scheme in respect of the declared special capital interim dividend and the proposed final dividends to be paid to Shareholders on 27 January 2012 and 15 February 2012 respectively. The Directors have no further immediate intention of exercising the above powers.
This resolution authorises the Company to purchase its own shares pursuant to section 701 of the 2006 Act. The authority is limited to an aggregate of 6,100,000 shares representing approximately 14.99% of the issued share capital of the Company as at the date of the notice of the meeting. The maximum price that may be paid for a share will be the higher of (i) an amount that is not more than five per cent above the average of the middle market quotations of the shares as derived from the Daily Official List of the UK Listing Authority for the five business days preceding such purchase and (ii) the price stipulated by Article 5(i) of the Buy Back and Stabilisation Regulations. The minimum price that may be paid for a share is 1 pence, being the nominal value thereof.
Venture Capital Trusts experience restricted market liquidity in their shares. The Board believes that it is in the best interests of the Company and Shareholders for the Company to be in a position to make occasional market purchases of its shares. This resolution will enable the Directors to carry out this policy.
Shareholders should note that the Directors will not exercise this authority unless they believe to do so would result in an increase in net assets per share and would be in the interests of Shareholders generally. The Directors currently intend to cancel all shares purchased under this authority. This resolution, will expire on the conclusion of the Company's Annual General Meeting to be held in 2013.
(2) On 1 November 2011 the Company made a new investment of £1,878,124 into Ingleby (1879) Limited to support the MBO of EmAC Limited.
(3) On 9 November 2011, the Company sold its investment in App-DNA Group Limited to Citrix Systems Inc, for an initial consideration of approximately £14.6 million plus a further approximately £1.8 million of deferred consideration which could be receivable over the next four years.
Matrix Private Equity Partners LLP Secretary 22 December 2011
This report has been prepared by the Directors in accordance with the requirements of Schedule 8 of The Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008. A resolution to approve the report will be proposed at the Annual General Meeting to be held on 9 February 2012. The Company's independent auditors are required to give their opinion on the information provided on Directors' emoluments on page 38 of this report and this is explained further in their report to Shareholders on pages 49 - 50.
The remuneration of individual Directors is determined by the Nominations and Remuneration Committee within the framework set by the Board. The Committee comprises the full Board and is chaired by Helen Sinclair (Colin Hook until 5 December 2011). The Committee meets at least once a year and is responsible for reviewing the remuneration of the Directors. The Committee has access to independent advice where and when it considers it appropriate. However, it was not considered necessary to take any such advice during the year under review. The Directors fees have remained at £35,000 (Chairman) and £25,000 (Director) per annum since 1 January 2006. The supplement paid to members of the Investment Committee was increased from £5,000 to £6,000 per annum with effect from 1 October 2008. After the year-end in December 2011, each of the Directors received a one-off payment of £10,000 in respect of additional work carried out on specific projects for the Company.
The remuneration policy is set by the Board. The Directors' fees are reviewed annually by the Nominations and Remuneration Committee which determines the amount of fees to be paid to the Directors. No director is involved in determining his or her own remuneration. When considering the level of Directors' fees, the Committee takes account of remuneration levels elsewhere in the Venture Capital Trust industry and other relevant information. Since all the Directors are non-executive, the Company is not required to comply with the provisions of the UK Corporate Governance Code in respect of Directors' remuneration, except in so far as they relate specifically to non-executive directors. No portion of the fees paid to any of the Directors is related to performance. Details of the Directors' remuneration are disclosed on page 38 and in Note 6 to the Accounts on page 59. All the Directors are non-executive and the Company does not provide pension benefits to any of the Directors. The Company has not granted any Director any options over the share capital of the Company and the Company does not operate any longterm incentive plans for the Directors.
The Articles of Association provide that Directors may be appointed either by an ordinary resolution of the Company or by the Board provided that a person appointed by the Board shall be subject to re-election at the first Annual General Meeting following their appointment. Onethird of the Directors retire from office by rotation at each Annual General Meeting and the retiring Directors then become eligible for re-election in accordance with the Articles of Association. All Directors receive a formal letter of appointment setting out the terms of their appointment and their specific duties and responsibilities. A Director's appointment may be terminated on three months' notice being given by the Company and in certain other circumstances. All of the Directors are non-executive and none of the Directors has a service contract with the Company. No arrangements have been entered into between the Company and the Directors to entitle any of the Directors to compensation for loss of office.
The emoluments in respect of qualifying services of each person who served as a Director during the year were as set out in the table below. The Company does not have any schemes in place to pay to any of the Directors bonuses, benefits, share options or compensation for loss of office in addition to their Directors' fees.
| Total emoluments year to: | ||
|---|---|---|
| 30 September 2011 | 30 September 2010 | |
| £ | £ | |
| Colin Hook | 41,000 | 41,000 |
| Jonathan Cartwright | 31,000 | 5,167 |
| Helen Sinclair | 31,000 | 31,000 |
| Christopher Moore | - | 30,647 |
Aggregate emoluments in respect of qualifying services amounted to £103,000 (2010: £107,814). No sums were paid to third parties in respect of any of the Directors' services during the year under review.
The graph below charts the total cumulative shareholder return of the Ordinary Shares (assuming all dividends have been re-invested and excluding the tax reliefs available to Shareholders) since the Shares were first admitted to trading on 8 February 2008 compared to the FTSE SmallCap Index. The FTSE SmallCap is an industry recognised index of listed companies. Some consider it to be an appropriate index against which to measure the Company's performance. The total shareholder return has been re-based to 100 as at the beginning of the period shown. The Net Asset Value (NAV) total return has been shown separately on the graphs because the Directors believe it is a more accurate reflection of the Company's performance.
An explanation of the performance of the Company is given in the Chairman's Statement on pages 5 - 10 and in the Investment Manager's Review and Investment Portfolio Summary on pages 13 - 24.
By order of the Board
22 December 2011
The Directors have adopted the Association of Investment Companies (AIC) Code of Corporate Governance 2010 ("the AIC Code") for the financial year ended 30 September 2011. The Board has considered the principles and recommendations of the AIC Code by reference to the AIC Corporate Governance Guide for investment companies ("AIC Guide"). The AIC Code as explained by the AIC Guide, addresses all the principles set out in the UK Corporate Governance Code ("the UK Code"), as well as setting out additional principles and recommendations on issues that are of specific relevance to the Company.
The Board considers that reporting against the principles and recommendations of the AIC Code, and by reference to the AIC Guide (which incorporates the UK Code), will provide the most appropriate information to Shareholders.
The AIC Code was endorsed by the Financial Reporting Council (FRC) on 3 February 2006, and 30 September 2010 in respect of the 2010 edition. The FRC has confirmed that in complying with the AIC Code, the Company will meet its obligations in relation to the UK Code and paragraph 9.8.6 of the Listing Rules. The AIC Code is available online at:
www.theaic.co.uk/Documents/Technical/AICCodeofCorporateGovernance2010.pdf
This statement has been compiled in accordance with the FSA's Disclosure and Transparency Rule (DTR) 7.2 on Corporate Governance Statements.
The Board considers that the Company has fully complied with the AIC Code and the relevant provisions of the UK Code, as set out below.
The UK Code includes provisions relating to:
For the reasons set out in the AIC Guide, and as explained in the UK Code, the Board considers these provisions are not relevant to the Company, being an externally managed VCT. The Company has therefore not reported further in respect of these provisions.
The Board has further considered the principles detailed in the UK Code and believes that, insofar as they are relevant to the Company's business, the Company has complied with the provisions of the Combined Code throughout the financial year ended 30 September 2011 with the following exceptions:
The Board has not appointed a Senior Independent Director, as it does not believe that such an appointment is necessary when the Board is comprised solely of non-executive directors. As recommended in the AIC Code, this role is fulfilled, as appropriate, by the Chairman of the Audit Committee.
As is common practice among Venture Capital Trusts, the Directors are not appointed for specific terms. A Director's appointment may be terminated on three months' notice being given by the Company. For further information please see the Directors' Remuneration Report on pages 37 - 39.
The Company has a Board of three non-executive Directors. All the Directors are equally responsible under the law for the proper conduct of the Company's affairs. In addition, the Directors are responsible for ensuring that their policies and operations are in the best interests of all the Company's Shareholders and that the best interests of creditors and suppliers to the Company are properly considered.
The Board has considered whether each Director is independent in character and judgement and whether there are any relationships or circumstances which are likely to affect, or could appear to affect, the Director's judgement. It has concluded that all three Directors are independent except in respect of the contracts or investee companies in which they have declared an interest. It is the policy of the Directors not to participate in decisions concerning investee companies in which they hold an interest.
Helen Sinclair remains a Director of Matrix Income & Growth 4 plc and is therefore not considered to be independent of the Manager.
For the reasons described above, as well as in terms of their professional and personal integrity and experience, the Board has no hesitation in emphasising to Shareholders the independent nature of each individual director in terms of both their character and judgement. Full biographical detail on each director as recommended in the AIC are included on pages 25 - 26.
The Board assessed the independence of the Chairman on appointment and concluded that he fully met the independence criteria as identified in the UK Code, as re-stated in principle 1 of the AIC Code. As recommended by the AIC Code, the remaining Directors monitor the continuing independence of the Chairman, and inform the Chairman of their discussions. The significant directorships and time commitments of the Chairman and the other Directors are considered by the Board and are disclosed on pages 25 - 26.
The Directors have declared any existing or potential conflicts of interest and these are reviewed and authorised by the Board as appropriate in accordance with the procedures under the Articles of Association and applicable rules and regulations. The Articles allow the Directors not to disclose information relating to a conflict where to do so would amount to a breach of confidence. The Nominations & Remuneration Committee undertakes an annual review of the authorisations given by the Board.
The Directors were subject to election by Shareholders at the first Annual General Meeting after their appointment, and retire by rotation thereafter. For further details please see the Directors' Remuneration Report on pages 37 - 39. The Directors are therefore not appointed for specific terms.
Colin Hook has served on the Board for eleven years and Helen Sinclair is considered to be a non-independent director as a result of her directorship of Matrix Income & Growth 4 VCT plc. Both of these Directors have therefore agreed to offer themselves for re-election annually.
The Board has considered a policy on tenure and agreed that for a Company of this size and structure, it is not appropriate to insist on a director's period of service being limited to a set number of years or to set an age limit for the retirement of directors. The AIC Code does not explicitly make recommendations on the overall length of tenure for directors and has stated that it does not believe that there is any evidence that an individual director's lengthy service on a board may compromise his independence in the case of investment companies. It has specifically stated that investment company boards are perhaps more likely than most to benefit from having at least one director with considerably longer than nine years' experience. As part of its annual performance review, the Board has come to the conclusion that the length of service, experience and ability of its Directors enhances its performance. It does not believe that the length of service of any of the Directors has a negative effect on their independence and is satisfied with the balance of experience on the current Board. In particular, the Board considers that the Chairman's service of eleven years as a Director of Company is an asset that he brings to the Board.
Appointment letters for new directors include an assessment of the expected time commitment for each Board position and new directors are asked to give an indication of their other significant time commitments. The Board has adopted a formal process of recruitment for the appointment of new directors including, as appropriate, the use of advertising and recruitment consultants as well as drawing on Board members' extensive range of business contacts to attract the optimum number of high quality candidates. The Board will consider diversity, including gender, in making future appointments. The selection process involves interviews with the Board and meetings with representatives of members of the manager. New directors are provided with an induction pack and an induction session is arranged in conjunction with the Board, the Manager and the Administrator.
The effectiveness of the Board and the Chairman is reviewed regularly as part of the internal control process led by the Audit Committee. The Board has carried out an annual performance evaluation review during the year ended 30 September 2011.
A formal training programme has not been required during the year under review as all the Directors were experienced directors of listed companies. All of the Directors regularly attend conferences and workshops relevant to the VCT industry.
The Investment Committee comprises all three Directors, Helen Sinclair (Chairman), Colin Hook and Jonathan Cartwright. The Committee meets as necessary to consider the investment proposals put forward by the Manager. Investment guidelines have been issued to the Manager and the Committee ensures that these guidelines are adhered to. New investments and divestments are approved by written resolution of the Committee following discussion between committee members and are subsequently ratified by the Board. Investment matters are discussed extensively at Board meetings. During the year the Committee formally approved 24 investment/divestment approvals and met informally on numerous occasions.
The Audit Committee comprises all three Directors, Jonathan Cartwright (Chairman), Colin Hook and Helen Sinclair. The Committee meets at least twice a year to review the halfyearly and annual financial statements before submission to the Board, including meeting with the independent auditors. The Committee makes recommendations to the Board on the appointment, re-appointment and removal of the external auditors. It is responsible for monitoring the effectiveness of the Company's internal control systems and for reviewing the scope and results of the audit and ensuring its cost effectiveness. The Audit Committee held four formal meetings during the year with full attendance from each of the Directors on each occasion. The Committee met informally on other occasions.
The Nominations and Remuneration Committee comprises the full Board and was chaired by Colin Hook until 5 December 2011. Following the year-end, Helen Sinclair has been appointed to chair the Committee with effect from this date. The Committee meets at least once a year and comprises a majority of independent directors. In considering nominations, it is responsible for making recommendations to the Board concerning new appointments of Directors to the Board and its Committees; the periodic review of the composition of the Board and its Committees; and the annual performance review of the Board, the Directors and the Chairman including the ongoing review of each Director's actual or potential conflicts of interest which may arise as a result of the external business activities of Board members. In considering remuneration, it is responsible for reviewing the remuneration of the Directors and the Company's remuneration policy to ensure that it reflects the duties, responsibilities and value of time spent by the Directors on the business of the Company and makes recommendations to the Board accordingly. The Committee held one formal meeting during the year, which was fully attended by all the Directors, and met informally on other occasions.
The Board has satisfied itself that each of its Committees has sufficient resources to undertake their duties. All of the above Committees have written terms of reference, which detail their authority and duties. Shareholders may obtain copies of these by making a written request to the Company Secretary or via the Company's website:
www.incomeandgrowthvct.co.uk.
The Board meets at least quarterly and is in regular contact with the Manager between these meetings. The Board held eight formal meetings during the year with full attendance from each of the Directors at all of those meetings. The Board met informally on numerous other occasions.
The Board and the Manager aim to work together in a supportive, cooperative and open manner. The Board has overall responsibility for the Company's affairs including the determination of its investment policy. The Manager takes the initiative on most aspects of the Company's operations, under the guidance and formal approval of the Board and the Board has agreed policies with the Manager covering key operational issues. All investment, divestment and variation decisions are made by the Board having considered formal recommendations from the Manager. The Manager up-dates the Board on developments at each of the investee companies, including decisions and discussions at Board meetings, if appropriate, through quarterly valuation reports, presentations to quarterly Board meetings of the VCT and otherwise when specific issues requiring the Board's attention emerge. The Board has delegated to the Manager authority to attend and vote at General Meetings of each of the investee companies in the portfolio as its Corporate Representative. The Manager consults the Board concerning extraordinary agenda items particularly when a proposed resolution concerns an issue that may impact on the Company's economic interest. It is however authorised to vote as it thinks appropriate on standard agenda items.
The primary focus at Board meetings is the review of investment performance and associated matters as well as the monitoring of financial and other internal controls including maintenance of VCT status and the level of share price discount or premium. The Board regularly considers overall strategy. The Board monitors the investments made by the Manager to ensure that the overall investment portfolio is in line with the Company's Investment Policy. The Board also considers peer group performance, asset allocation and wider industry and economic issues in reviewing investment performance and strategy.
The Board has agreed a schedule of matters specifically reserved for decision by the Board. These include compliance with the requirements of the Companies Act 2006 and the Income Tax Act 2007, the UK Listing Authority and the London Stock Exchange; changes relating to the Company's capital structure or its status as a plc; board and committee appointments as recommended by the Nominations and Remuneration Committee and terms of reference of committees; material contracts of the Company and contracts of the Company not in the ordinary course of business.
A procedure has been adopted for individual Directors, in the furtherance of their duties, to take independent professional advice at the expense of the Company. The Directors have access to the advice and services of the Company Secretary, who is responsible to the Board for ensuring board procedures are followed. Both the appointment and removal of the Company Secretary is a matter for the Board as a whole. Where Directors have concerns, which cannot be resolved about the running of the Company or a proposed action, they are asked to ensure that their concerns are recorded in the Board minutes. On resignation, a Director who has any such concerns should provide a written statement to the Chairman, for circulation to the Board.
The Board reviews annually, and at other times as and when necessary, the Investment Services Agreement and the performance of the Manager, as well as service providers including the administrator, auditors, VCT status adviser, solicitors, bankers and registrars. Particular emphasis is placed on reviewing the Manager, in terms of investment performance, quality of information provided to the Board and remuneration. This work forms part of the Board's overall internal control procedures as discussed elsewhere.
The Board has considered the appointment of a management engagement committee and has concluded that this is not necessary because the Board is comprised entirely of nonexecutive directors.
The Board acknowledges that it is responsible for the Company's system of internal control. Internal control systems are designed to manage the particular needs of the Company and the risks to which it is exposed and can by their nature only provide reasonable and not absolute assurance against material misstatement or loss.
The Directors are responsible for the internal control systems of the Company and for reviewing their effectiveness. These aim to ensure the maintenance of proper accounting records, the reliability of the financial information used for publication and upon which business decisions are made, and that the assets of the Company are safeguarded. The financial controls operated by the Board include the authorisation of the investment strategy and regular reviews of the financial results and investment performance.
The Board has put in place ongoing procedures for identifying, evaluating and managing the significant risks faced by the Company. As part of this process an annual review of the control systems is carried out in accordance with the Turnbull guidelines for internal control. The review covers a consideration of the key business, operational, compliance and financial risks facing the Company and includes a review of the risks in relation to the financial reporting process. Each risk is considered with regard to: the controls exercised at Board level; reporting by service providers; controls relied upon by the Board; exceptions for consideration by the Board; responsibilities for each risk and its review period; and risk rating. As part of this process, investment risk is spread by means of a diverse investment portfolio, as more fully described in the Investment Manager's Review and Investment Portfolio Summary on pages 13 - 24). The Board reviews a schedule of key risks at each Board meeting which identifies the risk, controls, any deficiencies that have arisen in the quarter and action to be taken. Each Board meeting reviews the management accounts, and annual or half-yearly reports arising therefrom, prepared by the administrator.
The Board has delegated, contractually to third parties, the management of the investment portfolio, the procurement of safekeeping services for the documents of title to the Company's assets, the day-to-day accounting, company secretarial and administration requirements and the registration services. Each of these contracts was entered into after full and proper consideration by the Board of the quality and cost of services offered, including the financial control systems in operation in so far as they relate to the affairs of the Company. The Board receives and considers regular reports from the Manager and ad hoc reports and information are supplied to the Board as required. It remains the role of the Board to keep under review the terms of the Investment Services Agreement with the Manager. The Directors carry out an Annual Review of the performance of and contractual arrangements with the Manager.
The Board, assisted by the Audit Committee, carries out separate assessments in respect of the Annual and Half-Yearly Reports and other published financial information. As part of these reviews, the Board appraises all the relevant risks ensuing from the internal control process referred to above. The main aspects of the internal controls which have been in place throughout the year in relation to financial reporting are:
This system of internal control and the procedure for the review of control systems referred to above has been in place and operational throughout the year under review and up to the date of this Report. The assessment of the effectiveness of internal controls in managing risk was conducted on the basis of reports from the relevant service providers. The last review took place on 5 December 2011. The Board has identified no significant problems with the Company's internal control mechanisms.
The Company communicates with Shareholders and solicits their views where it is appropriate to do so. The Manager publishes a twice-yearly VCT shareholder newsletter which contains information on the portfolio and recent investment and corporate activity. Shareholders are welcome at the Annual General Meeting which provides a forum for Shareholders to ask questions of the Directors and the Manager and to discuss issues affecting the Company with them. Shareholders may contact the Chairman of the Audit Committee if they have concerns which contact through the Chairman or Manager has failed to resolve or for which such contact is inappropriate.
The Board as a whole approves the Annual Report to Shareholders. The Directors aim to ensure that the Chairman's Statement, Financial Highlights and the Investment Manager's Review and Investment Portfolio Summary (which comprises a full list of all the VCT investments in the Company's portfolio) present a balanced and understandable assessment of the Company's position and future prospects and that Shareholders are provided with sufficient information to enable them to understand the risk:reward balance to which they exposed by investing in the Company.
The Board normally has a direct involvement in the content of communications regarding major corporate events even if the Manager is asked to act as spokesman.
The notice of the Annual General Meeting accompanies this Annual Report, which is normally sent to shareholders allowing a minimum of 20 working days before each meeting. Separate resolutions are proposed for each substantive issue. The number of proxy votes received for each resolution is announced after each resolution has been dealt with on a show of hands and is published on the Company's website www.incomeandgrowthvct.co.uk.
The Directors' Remuneration Report, prepared in compliance with the Directors' Remuneration Report Regulations 2002, is contained on pages 37 - 39 of this Annual Report. The Report includes an explanation of the procedure for developing policy and determining the remuneration for individual directors.
The Statement of Directors' Responsibilities in respect of the accounts is set out on page 48 of this Annual Report.
The report of the independent auditor is set out on pages 49 - 50 of this Annual Report.
The Board regularly reviews and monitors the external auditor's independence and objectivity. As part of this it reviews the nature and extent of services supplied by the auditor to ensure that independence is maintained. The Audit Committee has concluded that it is in the interests of the Company to purchase tax services from the auditor due to its greater knowledge of the Company which improves efficiency. The Committee believes that audit independence has been maintained as the fees involved are relatively small compared to those for the audit, the work isundertaken by separate teams and does not involve undertaking any management role in preparing the information reported in the accounts.
As at the date of this Report the Company had not been notified of any beneficial interest exceeding 3% of the issued share capital of either class.
Details of the Company's share capital can be found in the Directors' Report on pages 29 - 30.
There are no restrictions on voting rights.
The rules concerning the election of directors are set out in the paragraph headed 'Terms of appointment' on page 37 of the Directors' Remuneration Report.
The Company may amend its articles of association ("the Articles") by special resolution in accordance with section 21 of the Companies Act.
The powers of the Directors have been granted by company law, the Company's articles and resolutions passed by the Company's members in general meeting. Resolutions are proposed annually at each annual general meeting of the Company to authorise the Directors to allot shares, disapply the pre-emption rights of members and buy-back the Company's own shares on behalf of the Company. These authorities are currently in place and resolutions to renew them will be proposed at the next AGM of the Company to be held on 9 February 2011.
The Board has assessed the Company's operation as a going concern. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Management Report which is included within the Chairman's Statement, the Investment Portfolio Summary, the Investment Manager's Review and the Directors' Report. The Directors have satisfied themselves that the Company continues to maintain a significant cash position and is currently raising additional funds. The majority of companies in the portfolio continue to trade profitably and the portfolio taken as a whole remains resilient and well diversified. The major cash outflows of the Company (namely investments, buy-backs and dividends) are within the Company's control. The Board's assessment of liquidity risk and details of the Company's policies for managing its capital and financial risks are shown in note 20 on pages 67 - 74. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the annual financial statements.
By order of the Board
Matrix Private Equity Partners LLP Secretary 22 December 2011
The Directors are responsible for preparing the Directors' Report, the Directors' Remuneration Report and the financial statements in accordance with applicable law and regulations. They are also responsible for ensuring that the Annual Report includes information required by the Listing Rules of the Financial Services Authority.
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that year. In preparing these financial statements the Directors are required to:
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company's website. Legislation in the United Kingdom governing the preparation and dissemination of the financial statements and other information included in annual reports may differ from legislation in other jurisdictions.
The Directors confirm to the best of their knowledge that:
The names and functions of the Directors are stated on pages 25 - 26.
For and on behalf of the Board:
Colin Hook Chairman 22 December 2011
We have audited the financial statements of The Income & Growth VCT plc for the year ended 30 September 2011 which comprise the Income Statement, the Balance Sheet, the Reconciliation of Movements in Shareholders' Funds, the Cash Flow Statement and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
As explained more fully in the Statement of Directors' Responsibilities, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Company's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the Directors; and the overall presentation of the financial statements. In addition, we read all the financial and nonfinancial information in the Annual Report to identify material inconsistencies with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.
In our opinion the financial statements:
In our opinion:
We have nothing to report in respect of the following:
Under the Companies Act 2006 we are required to report to you if, in our opinion:
Under the Listing Rules we are required to review:
for and on behalf of PKF (UK) LLP, Statutory auditor
London, UK 22 December 2011
| me Statement |
|---|
| Inco |
For the year ended 30 September 2011
| 30 September 2011 | ||||||
|---|---|---|---|---|---|---|
| Notes | Revenue | Total | Revenue | Total | ||
| £ | £ | £ | £ | £ | £ | |
| 10 | - | 10,870,219 | 10,870,219 | - | 2,986,059 | 2,986,059 |
| 10 | - | 343,231 | 343,231 | - | 15,412 | 15,412 |
| 2 | 1,654,663 | - | 1,654,663 | 730,447 | - | 730,447 |
| - | - | - | 12,295 | 36,886 | 49,181 | |
| 3 | (237,946) | (713,837) | (951,783) | (204,246) | (612,738) | (816,984) |
| 4 | (375,837) | - | (375,837) | (513,840) | - | (513,840) |
| 5 | - | (1,337,456) | (1,337,456) | - | - | - |
| - | - | - | (75,516) | - | (75,516) | |
| 1,040,880 | 9,162,157 | 10,203,037 | (50,860) | 2,425,619 | 2,374,759 | |
| 7 | (176,808) | 176,808 | - | - | - | - |
| 864,072 | 9,338,965 | 10,203,037 | (50,860) | 2,425,619 | 2,374,759 | |
| 9 | 2.21p | 23.83p | 26.04p | (0.20)p | 9.75p | 9.55p |
| Capital | Capital |
All the items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period. The total column is the Profit and Loss Account of the Company. There were no other recognised gains and losses in the year.
Other than the revaluation movements arising in investments held at fair value through profit and loss, there were no differences between the profit/(loss) as stated above and at historical cost.
The notes on pages 55 - 75 form part of these financial statements.
as at 30 September 2011
| Company number: 4069483 | as at 30 September 2011 | as at 30 September 2010 | |||||
|---|---|---|---|---|---|---|---|
| Notes | |||||||
| Fixed assets | £ | £ | £ | £ | £ | £ | |
| Investments at fair value | 10 | 37,162,382 | 28,116,479 | ||||
| Current assets | |||||||
| Debtors and prepayments | 11 | 280,709 | 162,076 | ||||
| Current investments | 12 | 11,682,461 | 8,708,573 | ||||
| Cash at bank | 19 | 1,577,420 | 106,536 | ||||
| 13,540,590 | 8,977,185 | ||||||
| Creditors: amounts falling due within one year | 13 | (212,717) | (488,968) | ||||
| Net current assets | 13,327,873 | 8,488,217 | |||||
| Provision for liabilities and charges | 5 | (1,337,456) | - | ||||
| Net assets | 49,152,799 | 36,604,696 | |||||
| Capital and reserves | |||||||
| Called up share capital | 15 | 406,920 | 369,709 | ||||
| Share premium account | 16 | 5,669,141 | 369,141 | ||||
| Capital redemption reserve | 16 | 187,309 | 170,811 | ||||
| Capital reserve - unrealised | 16 | 12,350,858 | 422,183 | ||||
| Special reserve | 16 | 17,139,273 | 23,105,248 | ||||
| Profit and loss account | 16 | 13,399,298 | 12,167,604 | ||||
| Equity Shareholders' funds | 49,152,799 | 36,604,696 | |||||
| Basic and diluted net asset value per share | |||||||
| Ordinary Shares | 17 | 120.79p | 99.01p |
The notes on pages 55 - 75 form part of these financial statements.
The financial statements were approved and authorised for issue by the Board of Directors on 22 December 2011 and were signed on its behalf by:
Director
For the year ended 30 September 2011
| Notes | Year ended 30 September 2011 £ |
Year ended 30 September 2010 £ |
|
|---|---|---|---|
| Opening shareholders' funds | 36,604,696 | 35,883,097 | |
| Net share capital bought back in the year | 15 | (1,475,019) | (966,118) |
| Net share capital subscribed for in the year | 15 | 5,353,709 | 61,721 |
| Profit for the year | 10,203,037 | 2,374,759 | |
| Dividends paid in the year | 8 | (1,533,624) | (748,763) |
| Closing shareholders' funds | 49,152,799 | 36,604,696 |
-
The notes on pages 55 - 75 form part of these financial statements.
For the year ended 30 September 2011
| Operating activities | Notes | £ | 30 September 2011 | 30 September 2010 | |
|---|---|---|---|---|---|
| £ | £ | £ | |||
| Investment income received | 1,571,454 | 687,327 | |||
| VAT received and interest thereon | 34,370 | 144,206 | |||
| Other income | 3,647 | 4,053 | |||
| Investment management fees paid | (1,160,893) | (595,053) | |||
| Other cash payments | (480,615) | (508,610) | |||
| Merger costs paid by the company | - | (75,516) | |||
| Net cash outflow from operating activities | 18 | (32,037) | (343,593) | ||
| Investing activities | |||||
| Acquisition of investments | 10 | (2,739,946) | (6,514,315) | ||
| Disposal of investments | 10 | 4,907,493 | 1,289,635 | ||
| Net cash inflow/(outflow) from investing activities | 2,167,547 | (5,224,680) | |||
| Equity Dividends | |||||
| Payment of equity dividends | 8 | (1,533,624) | (748,763) | ||
| Net cash inflow/(outflow) before liquid resource management and | |||||
| financing | 601,886 | (6,317,036) | |||
| Management of liquid resources | |||||
| (Increase)/decrease in monies held pending investment | 19 | (2,973,888) | 7,253,497 | ||
| Financing | |||||
| Issue of Ordinary Shares | 15 | 5,353,709 | 61,721 | ||
| Purchase of own shares | (1,510,823) | (947,284) | |||
| 3,842,886 | (885,563) | ||||
| Increase in cash for the year | 19 | 1,470,884 | 50,898 |
The notes on pages 55 - 75 form part of these financial statements.
For the year ended 30 September 2011
A summary of the principal accounting policies, all of which have been applied consistently throughout the year, is set out below:
The accounts have been prepared under UK Generally Accepted Accounting Practice (UK GAAP) and the Statement of Recommended Practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ("the SORP") issued by the Association of Investment Companies in January 2009.
The results for the year to 30 September 2010 reflect the activities of what were previously the 'O' Share Fund and the 'S' Share Fund of the Company up until the funds were merged on 29 March 2010, after which they reflected the activity of the merged funds.
In order to better reflect the activities of a VCT and in accordance with the SORP, supplementary information which analyses the Income Statement between items of a revenue and capital nature has been presented alongside the Income Statement. The revenue column of the profit attributable to equity shareholders is the measure the Directors believe appropriate in assessing the Company's compliance with certain requirements set out in section 274 Income Tax Act 2007.
All investments held by the Company are classified as "fair value through profit and loss", in accordance with the International Private Equity and Venture Capital Valuation ("IPEVCV") guidelines, as updated in September 2009, which have not materially changed the results reported last year. This classification is followed as the Company's business is to invest in financial assets with a view to profiting from their total return in the form of capital growth and income.
For investments actively traded on organised financial markets, fair value is generally determined by reference to Stock Exchange market quoted bid prices at the close of business on the balance sheet date. Purchases and sales of quoted investments are recognised on the trade date where a contract of sale exists whose terms require delivery within a time frame determined by the relevant market. Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional.
Unquoted investments are stated at fair value by the Directors in accordance with the following rules, which are consistent with the IPEVCV guidelines:
All investments are held at the price of a recent investment for an appropriate period where there is considered to have been no change in fair value. Where such a basis is no longer considered appropriate, the following factors will be considered:
become realised. This is based upon an assessment of objective evidence of that investment's future prospects, to determine whether there is potential for the investment to recover in value.
Monies held pending investment are invested in financial instruments with same day or two-day access and as such are treated as current investments, and have been valued at fair value.
Dividends receivable on quoted equity shares are brought into account on the ex-dividend date. Dividends receivable on unquoted equity shares are brought into account when the Company's right to receive payment is established and there is no reasonable doubt that payment will be received.
Interest income on loan stock and dividends on preference shares are accrued on a daily basis. Provision is made against this income where recovery is doubtful. Where the loan stocks only require interest or a redemption premium to be paid on redemption, the interest and redemption premium is recognised as income once redemption is reasonably certain. Until such date interest is accrued daily and included within the valuation of the investment.
(i) Realised (included within the Profit and Loss Account reserve) The following are accounted for in this reserve:
Increases and decreases in the valuation of investments held at the year-end are accounted for in this reserve, except to the extent that the diminution is deemed permanent.
In accordance with stating all investments at fair value through profit and loss, all such movements through both revaluation and realised capital reserves are now shown within the Income Statement for the year.
The cost of share buy-backs are charged to this reserve. In addition, any realised losses on the sale of investments, and 75% of the management fee expense, and the related tax effect, are transferred from the Profit and Loss Account reserve to this reserve.
All expenses are accounted for on an accruals basis.
25% of the Investment Manager's fees are charged to the revenue column of the Income Statement, while 75% is charged against the capital column of the Income Statement. This is in line with the Board's expected long-term split of returns from the investment portfolio of the Company.
100% of any performance incentive fee payable for the period is charged against the capital column of the Income Statement, as it is based upon the achievement of capital growth.
Expenses are charged wholly to revenue, with the exception of expenses incidental to the acquisition or disposal of an investment, which are written off to the capital column of the Income Statement or deducted from the disposal proceeds as appropriate.
In the case of litigation costs (see note 5), all costs have been incurred to preserve the value of the investment in an investee company and as a result are 100% chargeable to the capital column of the Income Statement.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the Company's taxable profits and its results as stated in the financial statements that arise from the inclusion of gains and losses in the tax assessments in periods different from those in which they are recognised in the financial statements.
Deferred tax is measured at the average tax rates that are expected to apply in the years in which the timing differences are expected to reverse based on tax rates and laws that have been enacted or substantially enacted at the balance sheet date. Deferred tax is measured on a non-discounted basis.
A deferred tax asset is recognised only to the extent that it is more likely than not that future taxable profits will be available against which the asset can be utilised.
Any tax relief obtained in respect of management fees allocated to capital is reflected in the capital reserve – realised and a corresponding amount is charged against revenue. The tax relief is the amount by which corporation tax payable is reduced as a result of these capital expenses.
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Income from investments | ||
| – from equities | 365,331 | 200,605 |
| – from OEIC funds | 56,580 | 73,446 |
| – from loan stock | 1,212,795 | 442,132 |
| – from bank deposits | 16,309 | 664 |
| – from VAT recoverable | - | 9,547 |
| 1,651,015 | 726,394 | |
| Other income | 3,648 | 4,053 |
| Total income | 1,654,663 | 730,447 |
| Total income comprises | ||
| Revenue dividends received | 421,911 | 274,051 |
| Interest | 1,229,104 | 452,343 |
| Other income | 3,648 | 4,053 |
| Total Income | 1,654,663 | 730,447 |
| Income from investments comprises | ||
| Listed UK securities | 61,539 | 16,863 |
| Listed overseas securities | 56,580 | 73,446 |
| Unlisted UK securities | 1,516,587 | 625,874 |
| Total Income | 1,634,706 | 716,183 |
Loan stock interest above is stated after deducting an amount of £nil (2010: £216), being a provision made against loan stock interest regarded as collectable in previous years.
Total loan stock interest due but not recognised in the year was £428,557 (2010: £538,899).
| Revenue | Capital | Total | Revenue | Capital | Total | |
|---|---|---|---|---|---|---|
| 2011 | 2011 | 2011 | 2010 | 2010 | 2010 | |
| £ | £ | £ | £ | £ | £ | |
| Matrix Private Equity Partners LLP | 237,946 | 713,837 | 951,783 | 204,246 | 612,738 | 816,984 |
Under the terms of a revised investment management agreement dated 29 March 2010, Matrix Private Equity Partners LLP ("MPEP") provides investment advisory, administrative and company secretarial services to the Company, for a fee of 2.4% per annum of closing net assets, calculated on a quarterly basis by reference to the net assets at the end of the preceding quarter. One sixth of this fee is subject to minimum and maximum limits of £150,000 (2010: £130,000) and £170,000 (2010: £150,000) per annum respectively.
This agreement replaced the previous agreements with MPEP and with Matrix-Securities Limited dated 13 October 2000 (but amended by a deed of variation dated 12 September 2007), which were all terminated on 29 March 2010.
The investment management expense disclosed above is stated after applying a cap on expenses excluding IFA trail commission and exceptional items set at 3.25% of closing net assets at the year-end at the company level. In accordance with the investment management agreement any excess expenses are wholly borne by the Investment manager. The excess expenses during the year attributable to the Investment Manager amounted to £nil (2010: £nil).
Under a Deed of Termination and Variation relating to Performance Incentive Agreements dated 29 March 2010, the Investment Manager's Incentive Agreement for the former 'O' Share Fund has been continued while the former 'S' Share Fund's Incentive Agreement has been terminated. Under the terms of the premerger 'O' Share Fund Incentive Agreement, each of the ongoing Investment Manager, Matrix Private Equity Partners LLP ("MPEP") and a former Investment Manager, Foresight Group LLP ("Foresight") are entitled to a performance fee equal to 20% of the excess of the value of any realisation of an investment made after 30 June 2007, over the value of that investment in an Investment Manager's portfolio at that date ("the Embedded Value"), which value is itself uplifted at the rate of 6% per annum subject to a High Watermark test.
However, two amendments were made to this agreement for MPEP, the ongoing Investment Manager. Firstly, the High Watermark was increased by £811,430, being the 'S' Share Fund's shortfall in total net assets from net asset value of £1 per 'S' Share, at 31 December 2009. Secondly, only 70% of any new investment made by MPEP after the Merger will be added to the calculation of the Embedded Value, the value of the Investment Manager's portfolio and the value of any realisations, for the purposes of assessing any excess.
Under the above agreements, the Investment Manager is not entitled to an Incentive fee for the year ended 30 September 2011 (2010: £nil).
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Directors' remuneration (including NIC) (see note 6) | 113,701 | 118,758 |
| IFA trail commission | 114,121 | 138,907 |
| Administration fees - see note | - | 77,662 |
| Broker's fees | 11,938 | 11,687 |
| Auditors' fees – Audit of company | 27,440 | 24,455 |
| – Audit related assurance services | 4,980 | 4,242 |
| – Tax compliance services | 2,223 | 2,099 |
| VCT monitoring fees | 9,875 | 12,227 |
| Registrar's fees | 29,652 | 26,774 |
| Printing | 26,551 | 32,032 |
| Legal & professional fees | (1,819) | 25,693 |
| Directors' insurance | 8,681 | 8,925 |
| Listing and regulatory fees | 26,721 | 20,930 |
| Sundry | 1,773 | 9,449 |
| 375,837 | 513,840 |
The Administration fees in 2010 above arose from the Agreement with Matrix-Securities Limited referred to in Note 3 above, which was terminated on 29 March 2010.
| 5 | Litigation costs | ||
|---|---|---|---|
| 2011 | 2010 | ||
| £ | £ | ||
| Provision at the year-end and charge in the year | 1,337,456 | - |
Since the financial year end the Company, one of its investee companies Image Source Group Limited "IMSG" and another shareholder in IMSG reached agreement to settle an action brought by a former director and shareholder in IMSG. Under an agreement between the Company and IMSG dated 6 December 2011, IMSG has met the costs of the settlement including the Company's pro rata share of the legal fees incurred in defending the action up to 30 September 2011 and all the legal costs incurred since. To facilitate the settlement, the Company has lent approximately £1.5 million to IMSG on commercial terms and repayable in 5 years. The plaintiff to the action will also be entitled to a small percentage share of the net proceeds over and above £5 million attributable to the ordinary shareholders from any sale of IMSG up to 31 December 2016, after all loans and any outstanding interest costs and prior charges have been repaid. The loan has been reflected in the financial records of the Company since the financial year-end with a full provision against the carrying value.
As at the year-end, and therefore prior to the settlement described above, the Company had a prima facie obligation to meet potential costs arising from the action, as a co-respondent in the claim, the cost of which has been clarified after the year-end, as explained above. Accordingly, in these financial statements for the year ended 30 September 2011, the Company has made a provision of £1,337,456, being the £1.5 million total liability less costs not yet incurred by the year-end. In the Directors' opinion, this reliably quantifies the prima facie obligation that existed at the year-end.
| 2011 | 2010 | |
|---|---|---|
| Directors' emoluments | £ | £ |
| Colin Hook | 41,000 | 41,000 |
| Helen Sinclair | 31,000 | 31,000 |
| Jonathan Cartwright (appointed 1 August 2010) | 31,000 | 5,167 |
| Christopher Moore (resigned 24 September 2010) | - | 30,647 |
| 103,000 | 107,814 | |
| Employer's NIC and VAT | 10,701 | 10,944 |
| 113,701 | 118,758 |
No pension scheme contributions or retirement benefit contributions were paid. There are no share option contracts held by the Directors. Since all the Directors are non-executive, the other disclosures required by the Listing Rules are not applicable. The Company has no employees other than Directors.
| 2011 Revenue £ |
2011 Capital £ |
2011 Total £ |
2010 Revenue £ |
2010 Capital £ |
2010 Total £ |
|
|---|---|---|---|---|---|---|
| a) Analysis of tax charge: | ||||||
| UK Corporation tax on profits/(losses) for the year |
176,808 | (176,808) | - | - | - | - |
| Total current tax charge/(credit) | 176,808 | (176,808) | - | - | - | - |
Corporation tax is based on a rate of 20.5% (2010: 21%)
| b) Profit/(loss) on ordinary activities before tax Profit/(loss) on ordinary activities multiplied by small company rate of corporation tax in the UK of 20.5% (2010: |
1,040,880 | 9,162,157 | 10,203,037 | (50,860) | 2,425,619 | 2,374,759 |
|---|---|---|---|---|---|---|
| 21%) | 213,380 | 1,878,242 | 2,091,622 | (10,681) | 509,380 | 498,699 |
| Effect of: | ||||||
|---|---|---|---|---|---|---|
| UK dividends | (74,893) | - | (74,893) | (42,121) | - | (42,121) |
| Unrealised gains not taxable | - | (2,228,395) | (2,228,395) | - | (627,072) | (627,072) |
| Realised gains not taxable | - | (70,362) | (70,362) | - | (3,237) | (3,237) |
| Litigation costs | 274,178 | 274,178 | - | - | - | |
| Income not yet taxable | (552) | (552) | 450 | - | 450 | |
| Unrelieved expenditure | - | 8,402 | 8,402 | 36,494 | 120,929 | 157,423 |
| Impact of marginal rate | 38,873 | (38,873) | - | - | - | - |
| Expenses not deductible | - | - | - | 15,858 | - | 15,858 |
| Actual current tax charge | 176,808 | (176,808) | - | - | - | - |
Tax relief relating to investment management fees is allocated between revenue and capital where such relief can be utilised.
No asset or liability has been recognised for deferred tax in relation to capital gains or losses on revaluing investments as the Company is exempt from corporation tax in relation to capital gains or losses as a result of qualifying as a Venture Capital Trust.
There is no potential liability to deferred tax (2010: £nil). There is an unrecognised deferred tax asset of £450,000 (2010: £464,000).
| 2011 Revenue £ |
2011 Capital £ |
2011 Total £ |
2010 Revenue £ |
2010 Capital £ |
2010 Total £ |
|
|---|---|---|---|---|---|---|
| Dividends on equity shares | ||||||
| Ordinary Shares (formerly 'S' Shares) - Interim - year ended 30 September 2010 - 2p capital paid in February 2011 (2010: £nil) |
- | 765,916 | 765,916 | - | - | - |
| Ordinary Shares (formerly 'S' Shares) - final - year ended 30 September 2010 - 2p capital paid in March 2011 (2010 - 0.5p revenue). |
- | 767,708 | 767,708 | 52,668 | - | 52,668 |
| 'O' shares - final paid of £nil (2010: 0.5p revenue and 1.5p capital) per share: |
- | - | - | 178,754 | 517,341 | 696,095 |
| Total paid in year | 1,533,624 | 1,533,624 | 231,422 | 517,341 | 748,763 |
Any proposed final dividend is subject to approval by Shareholders at the Annual General Meeting and has not been included as a liability in these financial statements.
Set out below are the total income dividends payable in respect of the financial year, which is the basis on which the requirements of Section 259 of the Income Tax Act 2007 are considered.
| 2011 | 2010 | ||
|---|---|---|---|
| £ | £ | ||
| Revenue available by way of dividends for the year | 864,072 | (50,860) | |
| Proposed final income dividend for the year - 2p (2010: nil p) | 813,841 | N/A |
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Total earnings after taxation: | 10,203,037 | 2,374,759 |
| Basic and diluted earnings per share (note a) | 26.04p | 9.55p |
| Revenue profit/(loss) from ordinary activities after taxation | 864,072 | (50,860) |
| Basic and diluted revenue earnings per share (note b) | 2.21p | ( 0.20)p |
| Net unrealised capital gains on investments | 10,870,219 | 2,986,059 |
| Net realised capital gains on investments | 343,231 | 15,412 |
| Litigation costs | (1,337,456) | - |
| Recoverable VAT | - | 36,886 |
| Capitalised management fees less taxation | (537,029) | (612,738) |
| Total capital return | 9,338,965 | 2,425,619 |
| Basic and diluted capital earnings per share (note c) | 23.83p | 9.75p |
| Weighted average number of shares in issue in the year | 39,182,112 | 24,854,456 |
a) Basic earnings per share is total earnings after taxation divided by the weighted average number of shares in issue.
b) Revenue earnings per share is the revenue profit after taxation divided by the weighted average number of shares in issue.
c) Capital earnings per share is the total capital loss after taxation divided by the weighted average number of shares in issue.
d) Diluted earnings per share in each case are the same as basic earnings per share as no investment manager's incentive fee is payable in respect of the current year.
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Traded on AiM | 2,765,723 | 2,065,837 |
| Unquoted equity shares | 20,166,018 | 11,867,127 |
| Unquoted preference shares | 70,045 | 35,738 |
| Loan stock | 14,160,596 | 14,147,777 |
| Total | 37,162,382 | 28,116,479 |
| Brought forward net unrealised losses now realised | (1,058,456) | (2,869,899) |
| Realised gains during the year | 473,207 | 25,500 |
| Transaction costs | (129,976) | (10,088) |
| Total realised losses for the year | (715,225) | (2,854,487) |
| Unrealised gains for the year | 10,870,219 | 2,986,059 |
| Total gains for the year | 10,154,994 | 131,572 |
| Traded on AiM |
Unquoted Ordinary |
Preference shares |
Qualifying loans |
Total | |
|---|---|---|---|---|---|
| or OFEX | shares | ||||
| £ | £ | £ | £ | £ | |
| Cost at 30 September 2010 | 4,466,693 | 10,990,243 | 169,191 | 14,992,695 | 30,618,822 |
| Impairment | (450,000) | (2,474,526) | - | - | (2,924,526) |
| Unrealised (losses)/gains | (1,950,856) | 3,351,410 | (133,453) | (844,918) | 422,183 |
| Valuation at 30 September 2010 | 2,065,837 | 11,867,127 | 35,738 | 14,147,777 | 28,116,479 |
| - | |||||
| Purchases at cost | 279,996 | 347,588 | - | 2,112,362 (3,505,576 |
2,739,946 |
| Sales - proceeds | (628,000) | (893,893) | (10,000) | ) | (5,037,469) |
| Reclassification | - | (175,383) | 27,576 | 147,807 | - |
| Realised gains | 106,901 | 134,683 | - | 231,623 | 473,207 |
| Unrealised gains | 940,989 | 8,885,896 | 16,731 | 1,026,603 | 10,870,219 |
| Valuation at 30 September 2011 | 2,765,723 | 20,166,018 | 70,045 | 14,160,596 | 37,162,382 |
| Cost at 30 September 2011 | 4,286,189 | 11,104,773 | 86,766 | 14,139,876 | 29,617,604 |
| Impairment | (940,626) | (3,865,454) | - | - | (4,806,080) |
| Unrealised (losses)/gains at 30 September 2011 |
(579,840) | 12,926,699 | (16,721) | 20,720 | 12,350,858 |
| Valuation at 30 September 2011 | 2,765,723 | 20,166,018 | 70,045 | 14,160,596 | 37,162,382 |
Transaction costs on the purchase and disposal of investments of £129,976 were incurred in the year. These are excluded from realised gains shown above of £473,207, but were included in arriving at gains on realisation of investments in the Income Statement of £343,231.
The difference between disposals in the investments note above of £5,037,469 and the disposals figure per the Cash Flow Statement of £4,907,493 is £129,976 relating to transaction costs.
The amounts provided below cost at the end of the year or written-off against unlisted investments were as follows:
| Total Provisions at end of year | Write-offs/(write-backs) in year | |
|---|---|---|
| Financial Year | £ | £ |
| 2011 | 11,206,678 | 1,881,554 |
| 2010 | 11,575,422 | 2,524,527 |
| 2009 | 10,537,427 | 300,000 |
| 2008 | 8,588,728 | 1,439,350 |
| 2007 | 6,690,435 | 592,011 |
| 2006 | 6,268,991 | 5,522,339 |
| 2005 | 8,665,187 | 523,651 |
Details of the movements in unrealised gains and losses in the year are disclosed within the Investment Portfolio Summary on pages 22 - 24.
Amaldis (2008) Limited was disposed of during the year realising net proceeds of £1,465,328 plus a loan stock valued at £537,948, totalling £2,003,633. The carrying value at 30 September 2010 was £1,965,586. There was a full realisation of Campden Media Limited, generating proceeds of £287,239 and a realised loss against cost of £47,641. IGLU.com Holidays Limited prepaid their loan stock in full realising £997,675 and a premium of £150,000. Three part disposals of Tikit Group plc occurred during the year generating net proceeds of £625,485 and a realised gain over cost totalling £317,500.
Unrealised gains of £10,870,219 include a valuation uplift of £10,875,962 relating to App-DNA Group Limited which was sold shortly after the year end.
During the year, the Company treated five investments as wholly or partly permanently impaired, totalling £1,981,554. An investment previously impaired for £100,000 was dissolved so this impairment has been removed, the net movement of which explains the write-off of £1,881,554 above.
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Accrued income | 191,592 | 112,032 |
| Prepayments | 15,044 | 15,674 |
| Other debtors | 74,073 | 34,370 |
| 280,709 | 162,076 |
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Money-market liquidity funds:- | ||
| Royal Bank of Scotland Sterling Liquidity Fund | 2,881,254 | 1,080,206 |
| Blackrock Investment Management (UK) Institutional Sterling Fund | 2,102,821 | 966,062 |
| Fidelity Institutional Cash Fund | 2,696,550 | 4,182,636 |
| Scottish Widows Investment Partnership Sterling Liquidity Fund | 1,434,069 | 1,424,000 |
| Prime Rate Capital Management | 2,567,767 | 1,055,669 |
| Monies held pending investment | 11,682,461 | 8,708,573 |
This comprises cash invested in four Dublin based and one UK based OEIC money market funds as shown in the table above. All of these sums are subject to immediate access. These sums are regarded as monies held pending investment. The manager of Prime Rate Capital Management liquidity fund is a member of Matrix Group Limited, as is MPEP. There are no arrangements in place to prevent duplicated management fees from these two different parts of the Matrix Group in view of the small amount of fees paid. Since the year-end these funds have been withdrawn from Prime Rate and redeployed across the other funds.
| 2011 | 2010 | ||
|---|---|---|---|
| £ | £ | ||
| Trade creditors | 22,705 | 33,262 | |
| Other creditors | 16,489 | 62,819 | |
| Accruals | 173,523 | 392,887 | |
| 212,717 | 488,968 |
At 30 September 2011 the Company held significant investments, amounting to 3% or more of the equity capital of an undertaking, in the following companies:
| Total investment (at value) |
Percentage of investee company's total equity |
||
|---|---|---|---|
| £ | £ | ||
| App-DNA Group Limited | 11,633,974 | 31.54% | |
| Fullfield Limited (Motorclean) | 1,718,189 | 11.74% | |
| ATG Media Holdings Limited | 1,675,368 | 8.53% | |
| ASL Technology Holdings Limited (formerly Apricot Trading limited) | 1,674,630 | 9.55% | |
| RDL Corporation Limited (formerly Aust Recruitment Group Limited) | 1,383,792 | 13.04% | |
| Blaze Signs Holdings Limited | 1,354,238 | 12.50% | |
| DiGiCo Europe Limited | 1,258,330 | 4.28% | |
| CB Imports Group limited | 1,025,448 | 6.00% | |
| Backbarrow Limited | 1,000,000 | 16.67% | |
| Bladon Castle Management Limited | 1,000,000 | 16.67% | |
| Rusland Management Limited | 1,000,000 | 16.33% | |
| Torvar Limited | 1,000,000 | 16.33% | |
| Westway Services (2010) Holdings Limited | 928,577 | 4.72% | |
| IGLU.com Holidays Limited | 888,657 | 8.14% | |
| Youngman Group Limited | 682,203 | 8.49% | |
| British International Holdings Limited | 646,718 | 4.99% | |
| Brookerpaks Limited | 576,042 | 17.07% | * |
| Duncary 8 Limited | 535,699 | 25.49% | |
| Camwood Enterprises Limited | 499,182 | 31.54% | |
| Faversham House Holdings Limited | 487,744 | 8.81% | |
| Aquasium Technology Limited | 486,319 | 16.67% | |
| Machineworks Software Limited | 407,310 | 9.21% | |
| Image Source Group Limited | 238,977 | 44.00% | * |
| Letraset Limited | 234,385 | 5.26% | |
| Alaric Systems Limited | 167,114 | 6.93% | |
| NexxtDrive Limited | 162,500 | 6.22% | * |
| Racoon International Holdings Limited | 157,755 | 7.71% | |
| Vectair Holdings Limited | 139,125 | 4.63% | |
| The Plastic Surgeon Holdings Limited | 101,521 | 6.09% | |
| Oxonica Limited | 69,624 | 10.62% | |
| Lightworks Software Limited | 54,138 | 9.21% | |
| Monsal Holdings Limited | 42,446 | 5.59% | * |
| DCG Group Limited | - | 10.73% | |
| PXP Holdings Limited | - | 6.75% | |
| Biomer Technology Limited | - | 4.40% |
* The percentage of equity held for these companies may be subject to further dilution of an additional 1% or more if, for example, management of the investee company exercise share options.
It is considered that, as permitted by FRS9, "Associates and Joint Ventures", the above investments are held as part of an investment portfolio, and that, accordingly, their value to the Company lies in their marketable value as part of that portfolio. In view of this, it is not considered that any of the above represent investments in associated undertakings.
All of the above companies are incorporated in the United Kingdom.
MPEP also advises Matrix Income and Growth VCT plc, Matrix Income and Growth 2 VCT plc and Matrix Income and Growth 4 VCT plc who have investments as at 30 September 2011 in the following:
| Matrix Income and Growth VCT plc * |
Matrix Income and Growth 2 VCT plc |
Matrix Income and Growth 4 VCT plc |
Total | % of equity held by funds managed by MPEP |
|
|---|---|---|---|---|---|
| at cost | at cost | at cost | at cost | ||
| £ | £ | £ | £ | % | |
| Blaze Signs Holdings Limited | 1,952,986 | 1,398,498 | 610,016 | 3,961,500 | 52.5 |
| Backbarrow Limited | - | 1,000,000 | 1,000,000 | 2,000,000 | 50.0 |
| Bladon Castle Management Limited | 1,000,000 | 1,000,000 | 2,000,000 | 50.0 | |
| Racoon International Limited | 1,663,816 | 878,527 | 406,805 | 2,949,148 | 49.0 |
| Torvar Limited | - | - | 1,000,000 | 1,000,000 | 49.0 |
| Rusland Management Limited | - | - | 1,000,000 | 1,000,000 | 49.0 |
| RDL Corporation Limited (formerly Aust Recruitment Group Limited) |
1,558,333 | 1,000,000 | 1,000,000 | 3,558,333 | 45.2 |
| Machineworks Software Limited (formerly VSI Limited) |
44,501 | 25,727 | 9,329 | 79,557 | 45.0 |
| Lightworks Software Limited (formerly VSI Limited) | 44,501 | 25,727 | 9,329 | 79,557 | 45.0 |
| Fullfield Limited | 1,840,383 | 1,160,549 | 1,280,879 | 4,281,811 | 41.0 |
| ATG Media Holdings Limited | 1,454,419 | 768,011 | 888,993 | 3,111,423 | 38.4 |
| PXP Holdings Limited | 2,326,872 | 1,163,436 | 679,549 | 4,169,857 | 37.3 |
| Iglu.com Holidays Limited | 216,569 | 152,326 | 133,779 | 502,674 | 35.0 |
| British International Limited | 2,068,182 | 1,160,000 | 295,455 | 3,523,637 | 34.9 |
| Letraset Limited | - | - | 150,000 | 150,000 | 34.7 |
| ASL Technology Holdings Limited | 1,912,945 | 1,360,130 | 1,257,135 | 4,530,210 | 34.0 |
| (formerly Apricot Trading Limited) | |||||
| Faversham House Holdings Limited | 527,214 | 374,870 | 346,488 | 1,248,572 | 31.4 |
| Duncary 8 Limited | - | - | 126,995 | 126,995 | 30.6 |
| DiGiCo Europe Limited | 963,102 | 495,651 | 495,652 | 1,954,405 | 30.0 |
| The Plastic Surgeon Holdings Limited | 742,817 | 392,264 | 458,837 | 1,593,918 | 30.0 |
| Youngman Group Limited | 1,000,052 | 1,000,052 | 500,026 | 2,500,130 | 29.7 |
| Monsal Holdings Limited | 1,291,200 | 845,897 | 697,727 | 2,834,824 | 27.7 |
| CB Imports Group Limited | 2,000,000 | - | 1,000,000 | 3,000,000 | 24.0 |
| Vectair Holdings Limited | 138,574 | 60,293 | 24,732 | 223,599 | 24.0 |
| Focus Pharma Holdings Limited | 1,250,411 | 660,238 | 772,451 | 2,683,100 | 13.0 |
| Westway Services Holdings (2010) Limited | 382,201 | - | 236,096 | 618,297 | 13.0 |
| Omega Diagnostics Group plc | 305,000 | 214,998 | 199,998 | 719,996 | 9.8 |
| Legion Group plc | 150,106 | 150,106 | 150,102 | 450,314 | 3.9 |
* - The cost for Matrix Income & Growth VCT plc includes the original cost of acquiring investments previously owned by Matrix Income & Growth 3 VCT plc.
| 2011 £ |
2010 £ |
|
|---|---|---|
| Allotted, called-up and fully paid: | ||
| Ordinary Shares of 1p each: 40,692,048 (2010: 36,970,891) | 406,920 | 369,709 |
| 406,920 | 369,709 |
Under the Joint VCT Offer for Subscription launched on 12 November 2010 and which closed on 30 June 2011, 5,239,609 ordinary shares were allotted at an average issue price of 1.056 pence per share, raising net proceeds of £5,236,340.
Under the terms of the Dividend Investment Scheme, a total of 131,313 (2010: 112,768 - 'O' Shares; 6,674 - 'S' Shares) were allotted during the year for a total consideration of £117,369 (2010: £55,414 – 'O' Shares; £6,307 – 'S' Shares).
During the year the Company purchased 1,649,765 (2010: 1,407,758) of its own ordinary shares for cash (representing 4.1% (2010: 3.8%) of the ordinary shares in issue at the year-end) at the prevailing market price for a total cost of £1,475,019 (2010: £966,118).
| Called up share capital |
Share premium account |
Capital redemption reserve |
Capital reserve (unrealised) (non distributable) |
Special reserve* (note a) |
Profit and loss account* (note b) |
|
|---|---|---|---|---|---|---|
| £ | £ | £ | £ | £ | £ | |
| At 1 October 2010 | 369,709 | 369,141 | 170,811 | 422,183 | 23,105,248 | 12,167,604 |
| Shares bought back | (16,498) | - | 16,498 | - | (1,475,019) | - |
| Shares issued Dividends re-invested |
52,396 | 5,183,944 | - | - | - | - |
| into new shares | 1,313 | 116,056 | - | - | - | - |
| Dividends paid Transfer between |
- | - | - | - | - | (1,533,624) |
| reserves (note a) Other expenses net of |
- | - | - | - | (4,490,956) | 4,490,956 |
| taxation Net unrealised gains on |
- | - | - | - | - | (537,029) |
| investments Provision for settlement |
- | - | - | 10,870,219 | - | - |
| of litigation costs Gains on disposal of |
- | - | - | - | - | (1,337,456) |
| investments (net of transaction costs) |
- | - | - | - | - | 343,231 |
| Realisation of previously unrealised |
||||||
| losses | - | - | - | 1,058,456 | - | (1,058,456) |
| Profit for the year | - | - | - | - | - | 864,072 |
| At 30 September 2011 | 406,920 | 5,669,141 | 187,309 | 12,350,858 | 17,139,273 | 13,399,298 |
* - Included within these reserves is an amount of £30,538,571 (2010: £35,272,852) which is considered distributable. The Special reserve has been treated as distributable in determining the amounts available for distribution.
Note a – the cancellation of the 'O' Share Fund Share Premium Account (as approved at the Annual General Meeting held on 13 February 2002 and Order of the Court dated 1 May 2002) and the cancellation of the 'S' Share Fund Share Premium Account (as approved at the Extraordinary General Meeting of the Company held on 9 October 2007 and Order of the Court dated 16 September 2009) and the subsequent merger of these reserves via the merger of the 'O' Share fund and 'S' Share fund on 29 March 2010 has provided the Company with a special reserve out of which it can fund buy-backs of shares as and when it is considered by the Board to be in the interests of the Shareholders, and to absorb any existing and future realised losses. As a result, the Company has a special reserve of £17,139,273. The transfer of £4,490,956 to the special reserve from the realised capital reserve above is the total of realised losses incurred by the Company this year.
Note b – the realised capital reserve and the revenue reserve together comprise the Profit and Loss Account of the Company shown in the Balance Sheet.
The Shareholders authorised the Company to purchase its own shares pursuant to section 701 of the Companies Act 2006 at the Annual General Meeting held on 16 February 2011. The authority was limited to a maximum number of 5,541,937 Ordinary Shares (this being approximately 14.99% of the issued Share capital at the date of the Notice of the meeting). This authority will, unless previously revoked or renewed, expire on the conclusion of the Annual General Meeting of the Company to be held in 2012. The minimum price which may be paid for an Ordinary Share is 1 penny per share, the nominal value thereof. The maximum price that may be paid for an Ordinary Share is an amount that is not more than 5% above the average of the middle market quotations of the shares as derived from the Daily Official List of the London Stock Exchange for the five business days preceding such purchase. The authorities provide that the Company may make a contract or contracts to purchase its own shares prior to the expiry of the authority which may be executed in whole or part after the expiry of such authority, and may purchase its shares in pursuance of any such contract. A resolution to renew these authorities will be proposed at the Annual General Meeting to be held on 9 February 2012.
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Net assets | 49,152,799 | 36,604,696 |
| Number of shares in issue | 40,692,048 | 36,970,891 |
| Basic and diluted net asset value per share | 120.79p | 99.01p |
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Profit on ordinary activities before taxation | 10,203,037 | 2,374,759 |
| Net unrealised gains on investments | (10,870,219) | (2,986,059) |
| Net gains on realisation of investments | (343,231) | (15,412) |
| (Increase)/decrease in debtors | (118,633) | 23,800 |
| Increase in creditors and accruals | 1,097,009 | 259,319 |
| Net cash outflow from operating activities | (32,037) | (343,593) |
| Cash | Liquid resources |
Total | |
|---|---|---|---|
| £ | £ | £ | |
| At beginning of year | 106,536 | 8,708,573 | 8,815,109 |
| Cash flows | 1,470,884 | 2,973,888 | 4,444,772 |
| At 30 September 2011 | 1,577,420 | 11,682,461 | 13,259,881 |
The Company's financial instruments in both years comprise:
The principal purpose of these financial instruments is to generate revenue and capital appreciation for the Company's operations. The Company has no gearing or other financial liabilities apart from short-term creditors. It is, and has been throughout the year under review, the Company's policy that no trading in derivative financial instruments shall be undertaken.
The Company held the following categories of financial instruments at 30 September 2011:
| 2011 | 2011 | 2010 | 2010 | |
|---|---|---|---|---|
| (Book | (Book | |||
| value) | (Fair value) | value) | (Fair value) | |
| Assets at fair value through profit and loss: | £ | £ | £ | £ |
| Investment portfolio | 37,162,382 | 37,162,382 | 28,116,479 | 28,116,479 |
| Current investments | 11,682,461 | 11,682,461 | 8,708,573 | 8,708,573 |
| Cash at bank | 1,577,420 | 1,577,420 | 106,536 | 106,536 |
| Loans and receivables | ||||
| Accrued income | 191,592 | 191,592 | 112,032 | 112,032 |
| Other debtors | 74,073 | 74,073 | 34,370 | 34,370 |
| Liabilities at amortised cost or equivalent | ||||
| Other creditors | (212,717) | (212,717) | (488,968) | (488,968) |
| Total for financial instruments | 50,475,211 | 50,475,211 | 36,589,022 | 36,589,022 |
| Non financial instruments | (1,322,412) | (1,322,412) | 15,674 | 15,674 |
| Total net assets | 49,152,799 | 49,152,799 | 36,604,696 | 36,604,696 |
The investment portfolio principally consists of unquoted investments (92.6%; 2010: 92.7%) and AiM quoted stocks (7.4%; 2010: 7.3%). The investment portfolio has a 100% (2010:100%) concentration of risk towards small UK based, sterling denominated companies, and represents 75.6% (2010: 76.8%) of net assets at the year-end.
Current investments are money market funds, discussed under credit risk below, which represent 23.8% (2010: 23.8%) of net assets at the year-end.
The main risks arising from the Company's financial instruments are due to fluctuations in market prices (market price risk), credit risk and cash flow interest rate risk, although liquidity risk and currency risk are also discussed below. The Board regularly reviews and agrees policies for managing each of these risks and they are summarised below. These have been in place throughout the current and preceding years.
Market price risk arises from uncertainty about the future valuations of financial instruments held in accordance with the Company's investment objectives. These future valuations are determined by many factors but include the operational and financial performance of the underlying investee companies, as well as market perceptions of the future performance of the UK economy and its impact upon the economic environment in which these companies operate. This risk represents the potential loss that the Company might suffer through holding its investment portfolio in the face of market movements.
The investments in equity and fixed interest stocks of unquoted companies that the Company holds are not traded and as such the prices are more uncertain than those of more widely traded securities. As, in a number of cases, the unquoted investments are valued by reference to price earnings ratios prevailing in quoted comparable sectors, their valuations are exposed to changes in the price earnings ratios that exist in the quoted markets.
The Board's strategy in managing the market price risk inherent in the Company's portfolio of equities and loan stock investments is determined by the requirement to meet the Company's investment objective, as set out at the front of this Annual Report. As part of the investment management process, the Board seeks to maintain an appropriate spread of market risk, and also has full and timely access to relevant information from the Investment Managers. No single investment is permitted to exceed 15% of total investment assets at the point of investment. The Investment Committee meets regularly and reviews the investment performance and financial results, as well as compliance with the Company's objectives. The Company does not use derivative instruments to hedge against market risk.
The Board believes that the Company's assets are mainly exposed to market price risk, as the Company is required to hold most of its assets in the form of £ denominated investments in small companies.
Although a small part of these assets are quoted on AiM, nearly all of these assets are unquoted. All of the investments made by the Investment Managers in unquoted companies, irrespective of the instruments the Company actually holds, (whether shares, preference shares or loan stock) carry a full market risk, even though some of the loan stocks may be secured on assets, but behind any prior ranking bank debt in the investee company.
The Board considers that the value of investments in equity and loan stock instruments are ultimately sensitive to changes in quoted share prices, insofar as such changes eventually affect the enterprise value of unquoted companies. The table below shows the impact on profit and net assets if there were to be a 20% movement in overall share prices, which might in part be caused by changes in interest rate levels. However, it is not considered possible to evaluate separately the impact of changes in interest rates upon the value of the Company's portfolios of investments in small, unquoted companies.
The sensitivity analysis below assumes that each of these sub categories of investments (shares, preference shares and loan stocks) held by the Company produces a movement overall of 20%, and that the actual portfolio of investments held by the Company is perfectly correlated to this overall movement in share prices. However, Shareholders should note that this level of correlation is unlikely to be the case in reality, particularly in the case of the loan stock instruments. This is because loan stock instruments would not share in the impact of any increase in share prices to the same extent as the equity instruments, as the returns are set by reference to interest rates and premiums agreed at the time of initial investment. Similarly, where share prices are falling, the equity instrument could fall in value before the loan stock instrument. It is not considered practical to assess the sensitivity of the loan stock instruments to market price risk in isolation.
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| (as restated) | ||
| Profit and net assets | Profit and net assets | |
| If overall share prices fell by 20% (2010: 20%), with all other variables held constant – decrease |
(7,432,476) | (5,904,461) |
| Decrease in earnings, and net asset value, per Ordinary share (in pence) |
18.27p | 15.97p |
| 2011 | 2010 | |
| £ Profit and net assets |
£ Profit and net assets |
|
| If overall share prices increase by 20% (2010:20%), with all other variables held constant – increase |
7,432,476 | 5,904,461 |
| Increase in earnings, and net asset value, per Ordinary share (formerly S share) (in pence) |
||
| (18.27)p | (15.97)p |
The impact of a change of 20% has been selected as this is considered reasonable given the current level of volatility observed both on a historical basis and market expectations for future movement. The range in equity prices is considered reasonable given the historic changes that have been observed.
Credit risk is the risk that a counterparty will fail to discharge an obligation or commitment that it has entered into with the Company.
The Company's maximum exposure to credit risk is:
| 2011 | 2010 | |
|---|---|---|
| £ | £ | |
| Loan stock investments | 14,160,596 | 14,147,777 |
| Money market funds | 11,682,461 | 8,708,573 |
| Accrued income and other debtors | 265,665 | 112,032 |
| VAT recoverable | - | 34,370 |
| Cash at bank | 1,577,420 | 106,536 |
| 27,686,142 | 23,109,288 |
The Company has an exposure to credit risk in respect of the loan stock investments it has made into investee companies, most of which have no security attached to them, and where they do, such security ranks beneath any bank debt that an investee company may owe.
The accrued income and other debtor shown above was all due within two months of the year-end.
The following table shows the maturity of the loan stock investments referred to above. In some cases, the loan maturities are not the contractual ones, but are the best estimate using management's expectations of when it is likely that such loans may be repaid.
| 2011 | 2010 | |
|---|---|---|
| Repayable within | £ | £ |
| 0 to 1 year | 950,388 | 1,871,459 |
| 1 to 2 years | 4,649,493 | 548,170 |
| 2 to 3 years | 1,754,808 | 5,972,794 |
| 3 to 4 years | 1,839,573 | 3,075,862 |
| 4 to 5 years | 4,428,386 | 2,679,492 |
| > 5 years | 537,948 | - |
Total 14,160,596 14,147,777
Included within loan stock investments above are loans at a carrying value of £648,819 (2010: £695,833) which are past their repayment date but have been re-negotiated. Loans which are past their repayment date but which have not been renegotiated have a carrying value of £1,499,866 (2010: £1,572,176). These loan stock investments are made as part of the qualifying investments within the investment portfolio, and the risk management processes applied to the loan stock investments have already been set out under market price risk above.
An aged analysis of the loan stock investments included above, which are past due but not individually impaired, is set out below. For this purpose, these loans are considered to be past due when any payment due under the loan's contractual terms (such as payment of interest) is received late or missed. The loans in the table below are all considered to be past due only because interest on the loan is outstanding. We are required to report in this format and include the full value of the loan even though it is only in respect of interest that they are in default.
| 2011 | ||||
|---|---|---|---|---|
| 0-6 months |
6-12 months |
over 12 months |
Total | |
| £ | £ | £ | £ | |
| Loans to investee companies past due | 429,823 | - | 2,506,440 | 2,936,263 |
| 2010 | ||||
| 0-6 | 6-12 | over 12 | Total | |
| months £ |
months £ |
months £ |
£ | |
| Loans to investee companies past due | 1,391,392 | 173,870 | 2,677,906 | 4,243,168 |
There is a risk of default by the money market funds above, which could suffer defaults within their underlying portfolios that could affect the values at which the Company could sell its holdings. The Board manages credit risk in respect of these money market funds and cash by ensuring a spread of such investments such that none should exceed 15% of the Company's total investment assets. These money market funds are triple A rated funds, and so credit risk is considered to be relatively low in recent circumstances. The cash at bank figure of £1,577,420 is held with NatWest Bank plc, where the risk of default is considered to be low.
There could also be a failure by counter-parties to deliver securities which the Company has paid for, or pay for securities which the Company has delivered. This risk is considered to be small as most of the Company's investment transactions are in unquoted investments, where investments are conducted through solicitors, to ensure that payment matches delivery. In respect of any quoted investment transactions that are undertaken, the Company uses brokers with a high credit quality, and these trades usually have a short settlement period. Accordingly, counterparty risk is considered to be relatively low.
The Company's fixed and floating rate interest securities, its equity and preference equity investments and net revenue may be affected by interest rate movements. Investments are often in relatively small businesses, which are relatively high risk investments sensitive to interest rate fluctuations.
Due to the short time to maturity of some of the Company's floating rate investments, it may not be possible to re-invest in assets which provide the same rates as those currently held.
The Company's assets include fixed and floating rate interest instruments, as shown below. The rate of interest earned is regularly reviewed by the Board, as part of the risk management processes applied to these instruments, already disclosed under market price risk above.
The interest rate profile of the Company's net assets at 30 September 2011 was:
| Financial net assets on which no interest paid |
Fixed rate financial assets |
Variable rate financial assets |
Total | Weighted average interest rate |
Average period to maturity |
|
|---|---|---|---|---|---|---|
| £'000 | £'000 | £'000 | £'000 | % | (years) | |
| Equity shares | 22,931,741 | - | - | 22,931,741 | ||
| Preference shares | - | 70,045 | - | 70,045 | 2.04 | 2.59 |
| Loan stocks | - | 11,702,857 | 2,457,739 | 14,160,596 | 6.39 | 3.26 |
| Money market funds | - | - | 11,682,461 | 11,682,461 | 0.74 | - |
| Cash | - | - | 1,577,420 | 1,577,420 | ||
| Debtors | 265,665 | - | - | 265,665 | ||
| Creditors | (212,717) | - | - | (212,717) | ||
| Total for financial instruments | 22,984,689 | 11,772,902 | 15,717,620 | 50,475,211 | ||
| Other non financial assets | (1,322,412) | - | - | (1,322,412) | ||
| Total net assets | 21,662,277 | 11,772,902 | 15,717,620 | 49,152,799 | ||
The interest rate profile of the Company's financial net assets at 30 September 2010 was:
| Financial net assets on which no interest paid |
Fixed rate financial assets |
Variable rate financial assets |
Total | Weighted average interest rate |
Average period to maturity |
|
|---|---|---|---|---|---|---|
| £'000 | £'000 | £'000 | £'000 | % | (years) | |
| Equity shares | 13,932,964 | - | - | 13,932,964 | ||
| Preference shares | - | 35,738 | - | 35,738 | 4.00 | 1.27 |
| Loan stocks | - | 9,653,006 | 4,494,771 | 14,147,777 | 3.12 | 3.11 |
| Money market funds | - | - | 8,708,573 | 8,708,573 | 0.57 | - |
| Cash | - | - | 106,536 | 106,536 | ||
| Debtors | 146,402 | - | - | 146,402 | ||
| Creditors | (488,968) | - | - | (488,968) | ||
| Total for financial instruments | 13,590,398 | 9,688,744 | 13,309,880 | 36,589,022 | ||
| Other non financial assets | 15,674 | - | - | 15,674 | ||
| Total net assets | 13,606,072 | 9,688,744 | 13,309,880 | 36,604,696 |
Floating rate cash earns interest based on LIBOR rates.
The Company's investments in equity shares and similar instruments have been excluded from the interest rate risk profile as they have no maturity date and would thus distort the weighted average period information.
Although the Company holds investments in loan stocks that pay interest, the Board does not consider it appropriate to assess the impact of interest rate changes in isolation upon the value of the unquoted investment portfolio, as interest rate changes are only one factor affecting the market price movements that are discussed above under market price risk. However, as the Company has a substantial proportion of its assets in money market funds, the table below shows the sensitivity of income earned to changes in interest rates:
| 2011 £ |
2010 £ |
|
|---|---|---|
| Profit and net assets | Profit and net assets | |
| If interest rates fell by 1%, with all other variables held constant – decrease |
(125,741) | (105,148) |
| Decrease in earnings, and net asset value, per Ordinary share (in pence) |
(0.31)p | (0.28)p |
| 2011 £ Profit and net assets |
2010 £ Profit and net assets |
|
| If interest rates rose by 1%, with all other variables held constant – increase |
125,741 | 105,148 |
The investments in equity and fixed interest stocks of unquoted companies that the Company holds are not traded, they are not readily realisable. The ability of the Company to realise the investments at their carrying value may at times not be possible if there are no willing purchasers. The Company's ability to sell investments may also be constrained by the requirements set down for VCTs. The maturity profile of the Company's loan stock investments disclosed within the consideration of credit risk above indicates that these assets are also not readily realisable until dates up to five years from the year-end.
To counter these risks to the Company's liquidity, the Investment Manager maintains sufficient cash and money market funds to meet running costs and other commitments. The Company invests its surplus funds in high quality money market funds which are, as reported in Note 12, all accessible on an immediate basis.
All assets and liabilities are denominated in sterling and therefore there is no currency risk.
The table below sets out fair value measurements using FRS29 fair value hierarchy. The Company has one class of assets, being at fair value through profit and loss.
At 30 September 2011
| Level 1 £'000 |
Level 2 £'000 |
Level 3 £'000 |
Total £'000 |
|
|---|---|---|---|---|
| Equity investments | 2,765,723 | - | 20,166,018 | 22,931,741 |
| Preference shares | - | - | 70,045 | 70,045 |
| Loan stock investments | - | - | 14,160,596 | 14,160,596 |
| Money market funds | 11,682,461 | - | - | 11,682,461 |
| Total | 14,448,184 | - | 34,396,659 | 48,844,843 |
There are currently no financial liabilities at fair value through profit and loss.
Categorisation within the hierarchy has been determined on the basis of the lowest level input that is significant to the fair value measurement of the relevant asset as follows:
The valuation techniques used by the company are explained in the accounting policies in note 1.
There have been no transfers during the year between Levels 1 and 2. A reconciliation of fair value measurements in Level 3 is set out below:
| Equity investments |
Preference shares |
Loan stock investments |
Total | |
|---|---|---|---|---|
| £'000 | £'000 | £'000 | £'000 | |
| Opening balance at 1 October 2010 | 11,867,127 | 35,738 | 14,147,777 | 26,050,642 |
| Purchases | 347,588 | - | 2,112,362 | 2,459,950 |
| Sales | (893,893) | (10,000) | (3,505,576) | (4,409,469) |
| Transfers into Level 3 | - | - | - | - |
| Reclassification Total gains/(losses) included in gains/(losses) on investments in the Income Statement: |
(175,383) | 27,576 | 147,807 | - - |
| - on assets sold | 134,683 | - | 231,623 | 366,306 |
| - on assets held at the year end | 8,885,896 | 16,731 | 1,026,603 | 9,929,230 |
| Closing balance at 30 September 2011 | 20,166,018 | 70,045 | 14,160,596 | 34,396,659 |
As detailed in the accounting policies note, where investments are valued on an earnings-multiple basis, the main input used for this basis of valuation is a suitable price-earnings ratio taken from a comparable sector on the quoted market. These ratios are correlated to the share prices and so any change in share prices will have a significant effect on the fair value measurements of the investments classified as Level 3 investments.
Level 3 unquoted equity and loan stock investments are valued in accordance with the IPEVCV guidelines as follows:
| 30 September 2011 | 30 September 2010 | |
|---|---|---|
| £ | £ | |
| Investment methodology | ||
| Cost (reviewed for impairment) | 6,512,400 | 7,294,668 |
| Asset value supporting security held | - | 700,992 |
| Recent investment price | - | 994,657 |
| Earnings multiple | 16,180,661 | 17,060,325 |
| Realisation proceeds | 11,703,598 | - |
| 34,396,659 | 26,050,642 |
The unquoted equity investments had the following movements between valuation methodologies between 30 September 2011 and 30 September 2010:
| Change in investment methodology (2010 to 2011) | Carrying value as at 30 September 2011 £ |
Explanatory note |
|---|---|---|
| Cost (reviewed for impairment) to recent investment price |
- | More appropriate basis for determining fair value |
| Cost (reviewed for impairment) to earnings multiple | 167,114 | More appropriate basis for determining fair value |
| Asset value supporting security held to earnings multiple |
682,203 | More appropriate basis for determining fair value |
| Recent investment price to Cost (reviewed for impairment) |
42,446 | More appropriate basis for determining fair value |
| Earnings multiple to discounted realisation proceeds | 11,633,974 | More appropriate basis for determining fair value |
The valuation will be the most appropriate valuation methodology for an investment within its market, with regard to the financial health of the investment and the September 2009 IPEVCV guidelines. The directors believe that, within these parameters, there are no other possible methods of valuation which would be reasonable as at 30 September 2011.
FRS 29 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to the fair value measurement. The information used in determination of the fair value of Level 3 investments is chosen with reference to the specific underlying circumstances and position of the investee company. The portfolio has been reviewed and both downside and upside reasonable possible alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternatives, the value of the unquoted investments would be £2,611k or 7.6% lower. Using the upside alternatives the value would be increased by £1,869k or 5.4%. In arriving at both these figures, a 5% change to earnings multiples was applied, the earnings of five investee companies were increased and one was decreased where it was considered reasonable to do so and finally, the fair value of one investment was adjusted so that the impairment applied was reduced.
The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern, so that it can continue to provide returns for Shareholders and to provide an adequate return to Shareholders by allocating its capital to assets commensurately with the level of risk.
By its nature, the Company has an amount of capital, at least 70% (as measured under the tax legislation) of which is and must be, and remain, invested in the relatively high risk asset class of small UK companies within three years of that capital being subscribed. The Company accordingly has limited scope to manage its capital structure in the light of changes in economic conditions and the risk characteristics of the underlying assets. Subject to this overall constraint upon changing the capital structure, the Company may adjust the amount of dividends paid to Shareholders, return capital to Shareholders, issue new shares, or sell assets if so required to maintain a level of liquidity to remain a going concern.
Although, as the Investment Policy implies, the Board would consider levels of gearing, there are no current plans to do so. It regards the net assets of the Company as the Company's capital, as the level of liabilities are small and the management of them is not directly related to managing the return to Shareholders. There has been no change in this approach from the previous year.
There is only one class of business and the operations of the Company are wholly in the United Kingdom.
The Company has committed to invest a further £63,669 in further loan stock, to be issued by Monsal Holdings Limited.
On 15 December 2011, the Company approved a commitment to invest a further £45,195 in PXP Holdings Limited.
On 21 October 2011, £1,383,314 was invested into EOTH Limited (trading as Equip Outdoor Clothing Limited).
On 1 November 2011, £1,878,124 was invested in EMaC Limited.
On 10 November 2011, App DNA Group Limited was sold realising net proceeds of £14,542,468. As a result of this realisation, an incentive fee may be payable in respect of the year ended 30 September 2012. The final figure will not be known until after the calculation date of 30 September 2012, but the current estimated maximum payment is approximately £2.86m.
On 29 November 2011, Bladon Castle Management Limited redeemed its loan stock, realising proceeds of £999,000 for the Company. On 29 November 2011, the Company exchanged its shares in Bladon Castle Management Limited for shares in Watchgate Limited.
On 9 December 2011, the Company's investment in DiGiCo Europe Limited was sold to ISIS LLP for net cash proceeds of £1,405,642. In addition, the Company continues to hold a residual loan stock and equity (1.57%) investment.
(Registered in England and Wales No. 4069483)
NOTICE IS HEREBY GIVEN that the eleventh annual general meeting of The Income & Growth VCT plc ("the Company") will be held at 11.00 am on Thursday, 9 February 2012 at the offices of Matrix Group Limited, One Vine Street, London, W1J 0AH for the purposes of considering and, if thought fit, passing the following resolutions of which resolutions 1 to 8 will be proposed as ordinary resolutions and resolutions 9 and 10 will be proposed as special resolutions:-
where the proceeds of the allotment may be used in whole or in part to purchase the Company's shares in the market.
(iii) the maximum price which may be paid for a share shall be the higher of (i) 5% above the average of the middle market quotation for a share in the Company taken from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the purchase is made; and (ii) the amount stipulated by Article 5(1) of the Buy Back and Stabilisation Regulation (EC2273/2003).
(iv) the authority hereby conferred shall (unless previously renewed or revoked) expire on the conclusion of the annual general meeting of the Company to be held in 2013; and
Registered Office One Vine Street London W1J 0AH
22 December 2011
Colin Hook Jonathan Cartwright Helen Sinclair
One Vine Street London W1J 0AH
Matrix Private Equity Partners LLP One Vine Street London W1J 0AH
Company Registration Number: 4069483
www.incomeandgrowthvct.co.uk
PKF (UK) LLP Farringdon Place 20 Farringdon Road London EC1M 3AP
PricewaterhouseCoopers LLP 1 Embankment Place London WC2N 6RH
Capita Registrars The Registry 34 Beckenham Road Beckenham Kent BR3 4TU
Martineau No 1 Colmore Square Birmingham B4 6AA
The City Partnership (UK) Limited Thistle House Thistle Street Edinburgh EH2 1DF
National Westminster Bank plc Mayfair Commercial Banking Centre (First Floor) 65 Piccadilly London W1A 2PP
Matrix Corporate Capital LLP One Vine Street London W1J 0AH
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.